<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Mol Psychiatry</journal-id><journal-title-group><journal-title>Molecular Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">1359-4184</issn><issn pub-type="epub">1476-5578</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39681629</article-id><article-id pub-id-type="pmc">PMC12092276</article-id>
<article-id pub-id-type="publisher-id">2874</article-id><article-id pub-id-type="doi">10.1038/s41380-024-02874-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Electroconvulsive therapy-specific volume changes in nuclei of the amygdala and their relationship to long-term anxiety improvement in depression</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0009-0007-6855-0147</contrib-id><name><surname>Ishikawa</surname><given-names>Yuzuki</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0778-3381</contrib-id><name><surname>Oishi</surname><given-names>Naoya</given-names></name><address><email>noishi@kuhp.kyoto-u.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Kyuragi</surname><given-names>Yusuke</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hatakoshi</surname><given-names>Momoko</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hirano</surname><given-names>Jinichi</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Noda</surname><given-names>Takamasa</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Yoshihara</surname><given-names>Yujiro</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ito</surname><given-names>Yuri</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1803-1975</contrib-id><name><surname>Miyata</surname><given-names>Jun</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8623-9829</contrib-id><name><surname>Nemoto</surname><given-names>Kiyotaka</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Fujita</surname><given-names>Yoshihisa</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Igarashi</surname><given-names>Hiroyuki</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Takahashi</surname><given-names>Kento</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Murakami</surname><given-names>Shingo</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kanno</surname><given-names>Hiroyuki</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Izumi</surname><given-names>Yudai</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2985-6673</contrib-id><name><surname>Takamiya</surname><given-names>Akihiro</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4228-3208</contrib-id><name><surname>Matsumoto</surname><given-names>Junya</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Kodaka</surname><given-names>Fumitoshi</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Nakagome</surname><given-names>Kazuyuki</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Mimura</surname><given-names>Masaru</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6550-8188</contrib-id><name><surname>Murai</surname><given-names>Toshiya</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Suwa</surname><given-names>Taro</given-names></name><address><email>tarosuwa@kuhp.kyoto-u.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02kpeqv85</institution-id><institution-id institution-id-type="GRID">grid.258799.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0372 2033</institution-id><institution>Department of Psychiatry, Graduate School of Medicine, </institution><institution>Kyoto University, </institution></institution-wrap>Kyoto, Japan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02kpeqv85</institution-id><institution-id institution-id-type="GRID">grid.258799.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0372 2033</institution-id><institution>Human Brain Research Center, Graduate School of Medicine, </institution><institution>Kyoto University, </institution></institution-wrap>Kyoto, Japan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02kn6nx58</institution-id><institution-id institution-id-type="GRID">grid.26091.3c</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9959</institution-id><institution>Department of Neuropsychiatry, </institution><institution>Keio University School of Medicine, </institution></institution-wrap>Tokyo, Japan </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0254bmq54</institution-id><institution-id institution-id-type="GRID">grid.419280.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1763 8916</institution-id><institution>Department of Psychiatry, </institution><institution>National Center of Neurology and Psychiatry, </institution></institution-wrap>Tokyo, Japan </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02h6cs343</institution-id><institution-id institution-id-type="GRID">grid.411234.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 0727 1557</institution-id><institution>Department of Psychiatry, </institution><institution>Aichi Medical University, </institution></institution-wrap>Aichi, Japan </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02956yf07</institution-id><institution-id institution-id-type="GRID">grid.20515.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2369 4728</institution-id><institution>Department of Psychiatry, Institute of Medicine, </institution><institution>University of Tsukuba, </institution></institution-wrap>Ibaraki, Japan </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05f950310</institution-id><institution-id institution-id-type="GRID">grid.5596.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0668 7884</institution-id><institution>Neuropsychiatry, Department of Neurosciences, </institution><institution>Leuven Brain Institute, KU Leuven, </institution></institution-wrap>Leuven, Belgium </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02kn6nx58</institution-id><institution-id institution-id-type="GRID">grid.26091.3c</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9959</institution-id><institution>Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, </institution><institution>Keio University School of Medicine, </institution></institution-wrap>Tokyo, Japan </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0254bmq54</institution-id><institution-id institution-id-type="GRID">grid.419280.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1763 8916</institution-id><institution>Department of Pathology of Mental Diseases, National Institute of Mental Health, </institution><institution>National Center of Neurology and Psychiatry, </institution></institution-wrap>Tokyo, Japan </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/039ygjf22</institution-id><institution-id institution-id-type="GRID">grid.411898.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 0661 2073</institution-id><institution>Department of Psychiatry, </institution><institution>The Jikei University School of Medicine, </institution></institution-wrap>Tokyo, Japan </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0254bmq54</institution-id><institution-id institution-id-type="GRID">grid.419280.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1763 8916</institution-id><institution>National Center of Neurology and Psychiatry, </institution></institution-wrap>Tokyo, Japan </aff></contrib-group><pub-date pub-type="epub"><day>16</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>16</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>30</volume><issue>6</issue><fpage>2653</fpage><lpage>2664</lpage><history><date date-type="received"><day>24</day><month>4</month><year>2024</year></date><date date-type="rev-recd"><day>22</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>9</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Electroconvulsive therapy (ECT) is one of the most effective treatments for depression. ECT induces volume changes in the amygdala, a key center of anxiety. However, the clinical relevance of ECT-induced changes in amygdala volume remains uncertain. We hypothesized that nuclei-specific amygdala volumes and anxiety symptoms in depression could explain the clinical correlates of ECT-induced volume changes. To test this hypothesis, we enrolled patients with depression who underwent ECT (N&#x02009;=&#x02009;20) in this multicenter observational study and collected MRI data at three time points: before and after treatment and a 6-month follow-up. Patients who received medication (N&#x02009;=&#x02009;52), cognitive behavioral therapy (N&#x02009;=&#x02009;63), or transcranial magnetic stimulation (N&#x02009;=&#x02009;20), and healthy participants (N&#x02009;=&#x02009;147) were included for comparison. Amygdala nuclei were identified using FreeSurfer and clustered into three subdivisions to enhance reliability and interpretability. Anxiety symptoms were quantified using the anxiety factor scores derived from the Hamilton Depression Rating Scale. Before treatment, basolateral and basomedial subdivisions of the right amygdala were smaller than those of healthy controls. The volumes of the amygdala subdivisions increased after ECT and decreased during the follow-up period, but the volumes at 6-month follow-up were larger than those observed before treatment. These volume changes were specific to ECT. Long-term volume changes in the right basomedial amygdala correlated with improvements in anxiety symptoms. Baseline volumes in the right basolateral amygdala correlated with long-term improvements in anxiety symptoms. These findings demonstrate that clinical correlates of ECT-induced amygdala volume changes are existent, but in a nucleus and symptom-specific manner.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Neuroscience</kwd><kwd>Depression</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development (AMED)</institution></institution-wrap></funding-source><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><award-id>JP19dm0307102</award-id><principal-award-recipient><name><surname>Ishikawa</surname><given-names>Yuzuki</given-names></name><name><surname>Oishi</surname><given-names>Naoya</given-names></name><name><surname>Kyuragi</surname><given-names>Yusuke</given-names></name><name><surname>Hatakoshi</surname><given-names>Momoko</given-names></name><name><surname>Hirano</surname><given-names>Jinichi</given-names></name><name><surname>Noda</surname><given-names>Takamasa</given-names></name><name><surname>Yoshihara</surname><given-names>Yujiro</given-names></name><name><surname>Ito</surname><given-names>Yuri</given-names></name><name><surname>Miyata</surname><given-names>Jun</given-names></name><name><surname>Nemoto</surname><given-names>Kiyotaka</given-names></name><name><surname>Fujita</surname><given-names>Yoshihisa</given-names></name><name><surname>Igarashi</surname><given-names>Hiroyuki</given-names></name><name><surname>Takahashi</surname><given-names>Kento</given-names></name><name><surname>Murakami</surname><given-names>Shingo</given-names></name><name><surname>Kanno</surname><given-names>Hiroyuki</given-names></name><name><surname>Izumi</surname><given-names>Yudai</given-names></name><name><surname>Takamiya</surname><given-names>Akihiro</given-names></name><name><surname>Matsumoto</surname><given-names>Junya</given-names></name><name><surname>Kodaka</surname><given-names>Fumitoshi</given-names></name><name><surname>Nakagome</surname><given-names>Kazuyuki</given-names></name><name><surname>Mimura</surname><given-names>Masaru</given-names></name><name><surname>Murai</surname><given-names>Toshiya</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001691</institution-id><institution>MEXT | Japan Society for the Promotion of Science (JSPS)</institution></institution-wrap></funding-source><award-id>24K10808</award-id><award-id>21H02849</award-id><award-id>24K10678</award-id><principal-award-recipient><name><surname>Oishi</surname><given-names>Naoya</given-names></name><name><surname>Murai</surname><given-names>Toshiya</given-names></name><name><surname>Suwa</surname><given-names>Taro</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Depression is a neuropsychiatric disorder characterized by persistent feelings of sadness, loss of interest, and other psychosocial dysfunctions [<xref ref-type="bibr" rid="CR1">1</xref>]. Its heterogeneous symptom profiles and variability in individual responses to treatment make successful treatment procedures difficult, with approximately one-third of patients resistant to antidepressants [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Electroconvulsive therapy (ECT) is a highly effective treatment for treatment-resistant depression, with reported remission rates of 60&#x02013;80% [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. This remission rate is higher than that of other depression treatment modalities, such as medication, cognitive behavioral therapy (CBT), and transcranial magnetic stimulation (TMS) [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR6">6</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref>]. Despite its outstanding effectiveness, the neural mechanisms underlying the action of ECT are not fully understood [<xref ref-type="bibr" rid="CR9">9</xref>]. Furthermore, it remains unclear which neurobiological changes induced by ECT indicate the therapeutic effects. Identifying the neural substrates associated with the therapeutic effects of ECT is crucial for understanding depression mechanisms, and it may be the key to predicting treatment responsiveness. Consequently, previous studies have explored the neurobiological correlates of ECT at various levels [<xref ref-type="bibr" rid="CR10">10</xref>&#x02013;<xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par3">One established finding from studies on ECT is the extensive changes in brain volume, especially in limbic structures such as the hippocampus and amygdala [<xref ref-type="bibr" rid="CR13">13</xref>&#x02013;<xref ref-type="bibr" rid="CR16">16</xref>]. Studies on the hippocampus suggest that its volume increase is associated with changes in the markers of neural plasticity and synaptic structures, rather than being a result of edema or angiogenesis [<xref ref-type="bibr" rid="CR17">17</xref>&#x02013;<xref ref-type="bibr" rid="CR19">19</xref>]. Nevertheless, conflicting evidence exists regarding the relationship between volume increases and therapeutic effects [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR20">20</xref>&#x02013;<xref ref-type="bibr" rid="CR22">22</xref>], and a meta-analysis on the hippocampus reported no such associations [<xref ref-type="bibr" rid="CR13">13</xref>]. Similarly, previous findings on the relationship between volume changes in the amygdala and clinical outcomes have been inconsistent [<xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref>], complicating our understanding of its role in the therapeutic effects of ECT. Given the crucial role of the amygdala in anxiety, a core symptom of depression [<xref ref-type="bibr" rid="CR27">27</xref>&#x02013;<xref ref-type="bibr" rid="CR31">31</xref>], investigating the association between amygdala volume changes and the therapeutic effects of ECT is crucial for a comprehensive understanding of depression.</p><p id="Par4">The amygdala consists of structurally and functionally heterogeneous nuclei [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR32">32</xref>], which could explain the conflicting findings regarding its association with therapeutic effects. The basolateral complex of the amygdala integrates sensory inputs from the cortical regions and the thalamus, while the central nucleus of the amygdala relays information to modulate behavioral, physiological, and affective responses [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Thus, numerous animal studies have focused on the nucleus-specific characteristics of the amygdala [<xref ref-type="bibr" rid="CR34">34</xref>&#x02013;<xref ref-type="bibr" rid="CR36">36</xref>]. Additionally, several human studies have compared the volumes of amygdala nuclei in patients with depression to those in healthy individuals [<xref ref-type="bibr" rid="CR37">37</xref>&#x02013;<xref ref-type="bibr" rid="CR40">40</xref>]. These studies have suggested that therapeutic effects may not be evident when considering the amygdala as a singular entity but could be apparent at the nucleus level. Although there are several longitudinal studies on ECT-induced amygdala volume changes [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR41">41</xref>], only one study has examined the clinical associations of amygdala volume changes at the nucleus level [<xref ref-type="bibr" rid="CR26">26</xref>], possibly ignoring nucleus-level heterogeneity.</p><p id="Par5">Previous studies&#x02019; conflicting findings on the relationship with clinical outcomes may also stem from depression&#x02019;s symptom-level heterogeneity. Depressive symptoms are typically assessed using the total score of the Hamilton Depression Rating Scale (HAMD), Montgomery Asberg Depression Rating Scale (MADRS), or Beck Depression Inventory (BDI) [<xref ref-type="bibr" rid="CR42">42</xref>&#x02013;<xref ref-type="bibr" rid="CR44">44</xref>]. These rating scales reflect multiple symptom dimensions such as anhedonia and anxiety, which may hinder the understanding of treatment effects at the symptom level [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. Both human- and non-human studies have established the involvement of the amygdala in anxiety [<xref ref-type="bibr" rid="CR27">27</xref>&#x02013;<xref ref-type="bibr" rid="CR31">31</xref>]. Furthermore, in patients with depression, prelimbic functional connectivity features, particularly involving the amygdala, correlate with anxiety and sleep disturbances. However, these features do not correlate with anhedonia or psychomotor retardation [<xref ref-type="bibr" rid="CR47">47</xref>]. These findings highlight the importance of further investigation into how changes in amygdala volume induced by ECT relate to anxiety symptoms and the potential as a predictive biomarker for anxiety improvements.</p><p id="Par6">Furthermore, comparing ECT with other treatment modalities is crucial to better understanding the relationship between volume changes and the therapeutic effects. Various depression treatments may induce common neuroplastic changes such as synapse formation, increased neurotropic factors, or neurogenesis [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. In contrast, the therapeutic effects of ECT are more rapid than those of medications, suggesting that distinct neurobiological mechanisms underlie each treatment [<xref ref-type="bibr" rid="CR50">50</xref>]. Given these findings and the distinctive therapeutic effects of ECT, there is a clear need for cross-treatment comparisons. Previous studies have indicated that ECT-induced volume increases are transient and followed by subsequent decreases [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>], highlighting the importance of examining long-term changes. A previous study compared ECT with treatment as usual such as medication, structured psychotherapy, and case management, and found that the amygdala volume increase immediately after the completion of treatment was specific to ECT [<xref ref-type="bibr" rid="CR41">41</xref>]. However, findings on long-term volume changes across various treatment modalities are largely lacking, limiting our understanding of the long-term neural correlates of different treatment approaches.</p><p id="Par7">Therefore, this observational study aims to examine short- and long-term volume changes in the nuclei of the amygdala following ECT and other treatment modalities. Furthermore, the study aims to identify clinical correlates of the ECT-induced volume changes in the amygdala nuclei by focusing on their association with anxiety symptoms. To achieve our objectives, we included patients with depression who received ECT, medication, CBT, and TMS, as well as healthy participants. MRI images were acquired at three time points: pre-treatment, post-treatment, and at the 6-month follow-up. We hypothesized that (1) volume changes in the amygdala nuclei induced by treatment are specific to ECT across both short- and long-term durations, (2) a significant association exists between amygdala volumes and the effectiveness of treatment, particularly in its nuclei and anxiety symptoms, and (3) baseline volumes in the amygdala nuclei are predictive of subsequent improvements in anxiety symptoms.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and methods</title><sec id="Sec3"><title>Participants and study design</title><p id="Par8">Participants were recruited for the Longitudinal MRI study Identifying the Neural Substrates of Remission/Recovery in Mood Disorders (L/R Study), a constituent of the Brain MINDS/Beyond project [<xref ref-type="bibr" rid="CR53">53</xref>]. The study included 155 patients with depression (aged 20&#x02013;80 years; 74 men, 81 women) and 147 healthy participants (aged 20&#x02013;78 years; 59 men, 88 women) sourced from four sites. The demographic and clinical data of the participants are presented in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Demographics and clinical characteristics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Characteristic</th><th colspan="4">Study group</th><th colspan="2">Study group</th></tr><tr><th/><th>ECT</th><th colspan="3">Other treatment group</th><th/><th/></tr><tr><th/><th/><th>Medication</th><th>CBT</th><th>TMS</th><th>Depression</th><th>Healthy controls</th></tr></thead><tbody><tr><td>N</td><td>20</td><td>52</td><td>63</td><td>20</td><td>155</td><td>147</td></tr><tr><td>Sex (M/F)</td><td>7/13</td><td>31/21</td><td>25/38</td><td>11/9</td><td>74/81</td><td>59/88</td></tr><tr><td>Age, mean (SD), years</td><td>55.1 (17.1)</td><td>47.2 (15.6)</td><td>39.1 (13.1)*</td><td>43.4 (14.9)*</td><td>44.5 (15.6)</td><td>42.0 (13.1)</td></tr><tr><td/><td colspan="4">Clinical score</td><td colspan="2">Clinical score</td></tr><tr><td>Pre HAMD-17</td><td>25.0 (6.3)</td><td>14.7 (5.8)*</td><td>14.7 (4.4)*</td><td>15.8 (4.9)*</td><td>16.1 (6.2)</td><td>-</td></tr><tr><td>Post HAMD-17</td><td>7.8 (5.6)</td><td>8.3 (6.7)</td><td>8.4 (6.0)</td><td>10.3 (6.9)</td><td>8.6 (6.3)</td><td>-</td></tr><tr><td>Follow HAMD-17</td><td>6.7 (7.2)</td><td>7.1 (7.5)</td><td>7.3 (5.3)</td><td>9.5 (6.4)</td><td>7.4 (6.5)</td><td>-</td></tr><tr><td>Pre anxiety factor score</td><td>6.15 (2.22)</td><td>3.79 (1.74)*</td><td>3.72 (1.41)*</td><td>3.47 (1.79)*</td><td>4.03 (1.87)</td><td>-</td></tr><tr><td>Post anxiety factor score</td><td>1.72 (1.38)</td><td>2.30 (1.99)</td><td>2.25 (1.66)</td><td>2.09 (1.40)</td><td>2.18 (1.71)</td><td>-</td></tr><tr><td>6MA anxiety factor score</td><td>1.36 (1.61)</td><td>1.94 (2.10)</td><td>1.88 (1.57)</td><td>2.04 (1.93)</td><td>1.85 (1.81)</td><td>-</td></tr><tr><td>Remission at Post (yes/no)</td><td>11/9</td><td>26/26</td><td>31/32</td><td>10/10</td><td>78/77</td><td>-</td></tr><tr><td>Remission at 6MA (y/n)</td><td>14/6</td><td>27/25</td><td>31/32</td><td>8/12</td><td>80/75</td><td>-</td></tr><tr><td>Response at Post (y/n)</td><td>16/4</td><td>35/17</td><td>36/27</td><td>11/9</td><td>98/57</td><td>-</td></tr><tr><td>Relapse at 6MA (y/n)</td><td>2/9</td><td>1/25</td><td>8/23</td><td>3/7</td><td>14/64</td><td>-</td></tr></tbody></table><table-wrap-foot><p>Remission: HAMD-17&#x02009;&#x0003c;&#x02009;8. Response: &#x02267;50% HAMD-17 improvement.</p><p><italic>HAMD-17</italic> Hamilton 17-item Depression Rating Scale, <italic>ECT</italic> electroconvulsive therapy.</p><p>*<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 in comparison to the ECT group.</p></table-wrap-foot></table-wrap></p><p id="Par9">All patients were scheduled to receive either antidepressant medication, ECT, CBT, or TMS as part of their regular treatment based on the discretion of their attending psychiatrist at the time of recruitment. All patients met the criteria for major depressive disorder or persistent depressive disorder according to the DSM-5 [<xref ref-type="bibr" rid="CR1">1</xref>]. The key exclusion criteria encompassed substance use or alcohol misuse within the past 2 years, current suicidal ideation or suicide attempts in the past, current manic episodes or diagnosis of dementia, unstable medical condition, or other severe illnesses.</p><p id="Par10">All patients underwent MRI scanning and clinical assessments three times: within 2-weeks before (Pre) and after (Post) treatment, and 6 months after treatment (6MA). Healthy participants underwent MRI and clinical assessments twice at intervals of 6 or 16 weeks. Depressive symptoms were evaluated at each time point using the Hamilton 17-item Depression Rating Scale (HAMD-17) [<xref ref-type="bibr" rid="CR42">42</xref>]. Inclusion in the depression group required a HAMD-17 score of <inline-formula id="IEq1"><alternatives><tex-math id="d33e892">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\ge$$\end{document}</tex-math><mml:math id="d33e897"><mml:mo>&#x02265;</mml:mo></mml:math><inline-graphic xlink:href="41380_2024_2874_Article_IEq1.gif"/></alternatives></inline-formula> 8 at the time of the recruitment. All the participants provided written informed consent to participate in this study. An overview of the study timeline is depicted in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1"><label>Fig. 1</label><caption><title>Schematic overview of the study design.</title><p>Data acquisition was conducted across four institutions. All treatment groups underwent MRI scanning and clinical assessments three times: once each within 2-week periods before and after treatment (Pre and Post), and once in 6 months after treatment (6MA). Patients were assigned into four treatment groups based on the discretion of their attending psychiatrist. Healthy participants underwent MRI scanning and clinical assessments two times at intervals of 6 or 16 weeks. ECT electroconvulsive therapy, CBT cognitive behavioral therapy, TMS transcranial magnetic stimulation.</p></caption><graphic xlink:href="41380_2024_2874_Fig1_HTML" id="d33e911"/></fig></p></sec><sec id="Sec4"><title>Treatment</title><p id="Par11">The attending psychiatrist assigned patients to one of four treatment groups based on their discretion. The ECT group (N&#x02009;=&#x02009;20; aged 24&#x02013;80 years; 7 men and 13 women) received ECT sessions twice per week except for cases of severe physical illnesses (see <xref rid="MOESM1" ref-type="media">Supplementary Results</xref>). ECT treatment was performed using a brief pulse square-wave device (Thymatron System IV; Somatics, LLC, Venice, FL, USA). All patients in the ECT group met the criteria for ECT according to the American Psychiatric Association task force guidelines [<xref ref-type="bibr" rid="CR54">54</xref>]. Specifically, patients must be classified as treatment-resistant, urgent, or intolerant to pharmacotherapy. Treatment resistance was defined as the failure of two or more antidepressants administered at adequate dosages and for sufficient durations [<xref ref-type="bibr" rid="CR54">54</xref>]. Treatment sessions were continued if the patient did not experience symptom relief. Electrode placement was either bitemporal (N&#x02009;=&#x02009;9), bifrontal (N&#x02009;=&#x02009;9), or right unilateral (N&#x02009;=&#x02009;2). During the treatment course, two patients switched from bitemporal to bifrontal, and one patient switched from right unilateral to bifrontal. Anesthesia was induced using either propofol (1&#x02013;2&#x02009;mg/kg body weight, N&#x02009;=&#x02009;15), thiopental sodium (2&#x02013;4&#x02009;mg/kg body weight, N&#x02009;=&#x02009;3), ketamine (60&#x02009;mg, N&#x02009;=&#x02009;1), or sevoflurane (7.2&#x02013;8%, N&#x02009;=&#x02009;4). Decisions on the ECT treatment regimen were based on clinical assessments (e.g., responsiveness to previous ECT sessions, severity of depression). Detailed parameter settings are provided in Supplementary Methods and Table&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>. The medication group (N&#x02009;=&#x02009;52; aged 21&#x02013;78 years, 31 men and 21 women) included cases involving add-on therapy, switch medications, and treatment-na&#x000ef;ve cases. However, the core group consisted of add-on cases in which a single antidepressant was ineffective. The duration of treatment for the medication group was either 6 or 16 weeks. The CBT group (N&#x02009;=&#x02009;63; age range: 20&#x02013;79 years; 25 men, 38 women) underwent 16 consecutive 50-min sessions per week (16 weeks in total). The TMS group (N&#x02009;=&#x02009;20; age: 20&#x02013;74 years; 11 men, 9 women) underwent TMS sessions up to five times per week using a Neurostar TMS Therapy System (Malvern, PA, USA) with a figure-of-eight stimulation coil. Detailed parameter settings for TMS are provided in Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>. The concomitant use of antidepressants, mood stabilizers, antipsychotics, and anxiolytics was not prohibited in any treatment group.</p></sec><sec id="Sec5"><title>MRI acquisition</title><p id="Par12">MRI data were acquired using either one of six scanners installed at four different sites. All the images were acquired at a field strength of 3T. At Site 1 (Keio University, N&#x02009;=&#x02009;103), 3D T1-weighted brain images were collected using either a GE Discovery MR750 (GE HealthCare, Illinois, USA) or SIGNA HDxt (GE Healthcare). At sites 2 (Kyoto University, N&#x02009;=&#x02009;106), 3 (National Center Hospital, National Center of Neurology and Psychiatry, N&#x02009;=&#x02009;87), and 4 (The Jikei University, N&#x02009;=&#x02009;6), brain images were obtained using three-dimensional magnetization-prepared rapid acquisition with a gradient echo, utilizing a MAGNETOM Verio, MAGNETOM Skyra or MAGNETOM Skyra fit scanner (all from Siemens Healthineers, Erlangen, Germany). Detailed scanning parameters and correspondence between the treatment groups and scanners are provided in Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S3</xref>.</p></sec><sec id="Sec6"><title>MRI preprocessing</title><p id="Par13">The structural images underwent bias-field correction using Advanced Normalization Tools ver. 2.4.4. [<xref ref-type="bibr" rid="CR55">55</xref>] and were processed using the longitudinal standard pipeline [<xref ref-type="bibr" rid="CR56">56</xref>] in FreeSurfer ver. 7.3.2. This pipeline creates an unbiased within-subject template space and image using a robust, inverse-consistent registration based on outputs from the cross-sectional pipeline [<xref ref-type="bibr" rid="CR57">57</xref>]. Subsequently, the preprocessing steps were initialized with the new template image to enhance reliability and statistical power. Following preprocessing, the intracranial volumes (ICV) were extracted from the recon-all pipeline output and used for subsequent analyses.</p></sec><sec id="Sec7"><title>Amygdala segmentation</title><p id="Par14">The T1 longitudinal amygdala segmentation module in FreeSurfer ver. 7.3.2. [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>] was applied to bias-field-corrected, normalized, and skull-stripped images generated from the FreeSurfer longitudinal pipeline. This module employs a probabilistic atlas built using ultra-high-resolution ex vivo MRI data and image intensity to delineate nine amygdala nuclei [<xref ref-type="bibr" rid="CR59">59</xref>]. The longitudinal segmentation module provides a generative model-based joint segmentation of nuclei across multiple time points to yield more reliable subregional volumes [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]. The amygdala nuclei were visually inspected for quality assurance; however, no manual modifications were made to avoid introducing external bias.</p></sec><sec id="Sec8"><title>Amygdala nuclei clustering</title><p id="Par15">The FreeSurfer segmentation module exhibits high test-retest reliability for most nuclei. However, some nuclei show relatively low reliability, which is critical for making longitudinal comparisons [<xref ref-type="bibr" rid="CR60">60</xref>]. Additionally, these nuclei cannot be directly compared with the typical partitioning in prior human studies, where the amygdala was divided into two or three subdivisions [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. To address these problems, we clustered the nine amygdala nuclei into three subdivisions based on their anatomical plausibility and proximity [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR63">63</xref>] (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2A</xref>). The first subdivision consists of the lateral nucleus, basal nucleus, paralaminar nucleus, and anterior amygdala, collectively referred to as the basolateral (BL) subdivision. The second subdivision comprises the accessory basal nucleus and cortico-amygdaloid transition area, referred to as the basomedial (BM) subdivision. The third subdivision consists of the central, medial, and cortical nucleus, collectively referred to as the centromedial (CM) subdivision.<fig id="Fig2"><label>Fig. 2</label><caption><title>Amygdala subdivisions and their baseline volumes.</title><p><bold>A</bold> A representative image of the amygdala parcellation. (Left) Nine nuclei are identified from the FreeSurfer output. (Right) Three clustered subdivisions. The basolateral subdivision consists of the lateral, basal, paralaminar nucleus, and the anterior amygdaloid area. The basomedial subdivision is comprised of the accessory basal nucleus and the cortico-amygdaloid transition area. The centromedial subdivision consists of the central, cortical, and medial nucleus. <bold>B</bold> Test-retest reliability of the clustered subdivisions. The bilateral centromedial subdivisions showed a mean percentage volume error of &#x0003e;5% and were excluded from further analyses. <bold>C</bold> Baseline amygdala subdivision volumes of patients with depression and healthy controls. BL Basolateral, BM Basomedial, CM Centromedial, HC Healthy controls. *: <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 Bonferroni corrected.</p></caption><graphic xlink:href="41380_2024_2874_Fig2_HTML" id="d33e1021"/></fig></p></sec><sec id="Sec9"><title>Test-retest reliability of amygdala subdivision volumes</title><p id="Par16">To assess whether the test-retest reliability of the clustered amygdala subdivisions is adequate for longitudinal comparison, we quantified the test-retest reliability as the percentage volume error (&#x003b5;) between Pre and Post volume measurements of healthy controls [<xref ref-type="bibr" rid="CR64">64</xref>] using the following formula:<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="d33e1029">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{\rm{\varepsilon }}}=100\times \frac{{{|}}{V}_{{Pre}}-{V}_{{Post}}{{|}}}{({V}_{{Pre}}+{V}_{{Post}})/2}$$\end{document}</tex-math><mml:math id="d33e1035"><mml:mi mathvariant="normal">&#x003b5;</mml:mi><mml:mo>=</mml:mo><mml:mn>100</mml:mn><mml:mo>&#x000d7;</mml:mo><mml:mfrac><mml:mrow><mml:mo>&#x02223;</mml:mo><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02223;</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:math><graphic xlink:href="41380_2024_2874_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula>We established that a percentage volume error of less than 5% was sufficient for the longitudinal comparison [<xref ref-type="bibr" rid="CR60">60</xref>]. Therefore, subdivisions with errors greater than 5% were excluded from further analysis.</p></sec><sec id="Sec10"><title>Demographics and clinical data</title><p id="Par17">The mean and standard deviation for continuous variables, as well as the number and ratio of categorical variables were calculated using Python 3.8. <italic>t</italic>-tests and chi-squared tests were used to compare the differences between the ECT group and other treatment groups, and between the depression group and the healthy control group. Statistical significance was set to <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></sec><sec id="Sec11"><title>Harmonizing scanner differences</title><p id="Par18">Cross-sectional and longitudinal ComBat harmonization [<xref ref-type="bibr" rid="CR65">65</xref>&#x02013;<xref ref-type="bibr" rid="CR67">67</xref>] were used to adjust volumes for cross-scanner differences. ComBat is a batch-effect correction tool designed to remove inter-scanner technical variability while maintaining inter-scanner biological variability [<xref ref-type="bibr" rid="CR67">67</xref>]. Age, sex, ICV, and the clinical outcomes of interest were integrated into the batch-effect estimation to retain the effects of these variables. ComBat was performed separately using R 4.3.1 for each statistical analysis, and the same covariates were used for each analysis.</p></sec><sec id="Sec12"><title>Comparison of pre-treatment volume between patients with depression and healthy controls</title><p id="Par19">The baseline volumes of amygdala subdivisions in patients with depression were compared with those of healthy controls. To elucidate group differences, an analysis of covariance (ANCOVA) incorporating age, sex, and ICV as covariates was performed using R version 4.3.1. Statistical significance was set at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, with the Bonferroni correction adjusting for side (left, right) and subdivision (BL and BM).</p></sec><sec id="Sec13"><title>Longitudinal volume change</title><p id="Par20">First, repeated measures ANCOVA, with ICV as a covariate, was performed separately within each treatment group to examine whether there was a significant volume change between any of the time points. For significant results, post-hoc tests were performed using linear mixed-effects models with time and ICV as fixed effects and individuals as random intercepts to identify the significant changes between specific timepoint pairs (Pre and Post, Post and 6MA, and Pre and 6MA). The mean percentage of the volume change between each time point was calculated to illustrate the effect size. Spearman&#x02019;s rank correlation analysis was performed to examine the relationship between volume changes in the amygdala subdivisions and the number of ECT sessions. Statistical significance was set at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 with the Bonferroni correction adjusting for side (left, right) and subdivision (BL and BM). All statistical analyses were performed using R version 4.3.1.</p></sec><sec id="Sec14"><title>Association with anxiety factor score</title><p id="Par21">Factor loadings of the anxiety component in the HAMD-17, derived from a large-scale meta-analysis of more than 2600 patients [<xref ref-type="bibr" rid="CR45">45</xref>], were used to investigate the association between amygdala volume and anxiety symptoms in the ECT group. These loadings reflect the degree to which items co-occurred under the same factor in previous studies and are provided in the <xref rid="MOESM1" ref-type="media">Supplementary Methods</xref>. Confirmatory factor analysis of these factors showed a moderate-to-good fit, indicating their replicability [<xref ref-type="bibr" rid="CR68">68</xref>]. Partial correlations between baseline volume and anxiety factor scores, with age, sex, and ICV considered as covariates, were calculated.</p><p id="Par22">Changes in volume and anxiety factor scores were defined as the difference between two timepoints:<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="d33e1142">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\Delta {{{\rm{Volume}}}}_{{{\rm{tp}}}1\to {{\rm{tp}}}2}={{{\rm{Volume}}}}_{{{\rm{tp}}}2}-{{{\rm{Volume}}}}_{{{\rm{tp}}}1}$$\end{document}</tex-math><mml:math id="d33e1148"><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:msub><mml:mrow><mml:mi mathvariant="normal">Volume</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">tp</mml:mi><mml:mn>1</mml:mn><mml:mo>&#x02192;</mml:mo><mml:mi mathvariant="normal">tp</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Volume</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">tp</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Volume</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">tp</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math><graphic xlink:href="41380_2024_2874_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="d33e1182">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\Delta {{\rm{Anxiety}}}\; {{\rm{factor}}}\; {{\rm{score}}}_{{{\rm{tp}}}1\to {{\rm{tp}}}2} = 	 \,{{{\rm{Anxiety}}}\; {{\rm{factor}}}\; {{\rm{score}}}}_{{{\rm{tp}}}2}\\ 	 -{{{\rm{Anxiety}}}\; {{\rm{factor}}}\; {{\rm{score}}}}_{{{\rm{tp}}}1}$$\end{document}</tex-math><mml:math id="d33e1188"><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi mathvariant="normal">Anxiety</mml:mi><mml:mspace width="0.16em"/><mml:mi mathvariant="normal">factor</mml:mi><mml:mspace width="0.16em"/><mml:msub><mml:mrow><mml:mi mathvariant="normal">score</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">tp</mml:mi><mml:mn>1</mml:mn><mml:mo>&#x02192;</mml:mo><mml:mi mathvariant="normal">tp</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mrow><mml:mi mathvariant="normal">Anxiety</mml:mi><mml:mspace width="0.16em"/><mml:mi mathvariant="normal">factor</mml:mi><mml:mspace width="0.16em"/><mml:mi mathvariant="normal">score</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">tp</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Anxiety</mml:mi><mml:mspace width="0.16em"/><mml:mi mathvariant="normal">factor</mml:mi><mml:mspace width="0.16em"/><mml:mi mathvariant="normal">score</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">tp</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math><graphic xlink:href="41380_2024_2874_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula></p><p id="Par23">Partial correlation between &#x00394;volume and &#x00394;anxiety factor score with age, sex, and ICV as covariates was calculated for each timepoint. Additionally, partial correlation analysis between the baseline volume and &#x00394;anxiety factor score was performed to examine whether baseline volumes correlated with improvements in anxiety symptoms.</p><p id="Par24">Correlation analyses were also performed for the overall HAMD-17 scores to determine whether the anxiety component exhibited a greater correlation compared to the total HAMD-17 score. Statistical significance was set at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 with the Bonferroni correction adjusting for side (left, right) and subdivision (BL and BM). All statistical analyses in this section were performed using R version 4.3.1.</p></sec></sec><sec id="Sec15" sec-type="results"><title>Results</title><sec id="Sec16"><title>Clinical characteristics and treatment outcomes</title><p id="Par25">The overall post-treatment remission rate was 50.3% and did not differ across the treatment modalities (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). At the 6MA, the ECT group had the highest remission rate of 70%; however, this difference was not statistically significant compared with that of any other treatment group. The ECT group and each non-ECT treatment group did not differ in sex ratio, but they significantly differed in age, except for the medication group. The baseline HAMD-17 and anxiety factor scores were significantly different between the ECT and non-ECT treatment groups.</p></sec><sec id="Sec17"><title>Amygdala nuclei clustering</title><p id="Par26">The test-retest reliability of volumetrics increased after clustering the nine nuclei from the FreeSurfer output into three subdivisions (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2A, B</xref>, Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>). However, the bilateral CM subdivisions showed &#x0003e;5% volume error and were excluded from further analyses (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2B</xref>).</p></sec><sec id="Sec18"><title>Baseline amygdala subdivision volumes</title><p id="Par27">Baseline amygdala volumes in patients with depression were significantly lower in the right BL subdivision (<italic>F</italic>[1, 297]&#x02009;=&#x02009;6.99, <italic>P</italic>&#x02009;=&#x02009;0.009, <italic>d</italic>&#x02009;=&#x02009;0.27) and the right BM subdivision (<italic>F</italic>[1, 297]&#x02009;=&#x02009;8.12, <italic>P</italic>&#x02009;=&#x02009;0.005, <italic>d</italic>&#x02009;=&#x02009;0.29) compared with those of healthy controls (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2C</xref>, Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S4</xref>). None of the amygdala subdivisions exhibited significant partial correlations with the total HAMD-17 or anxiety factor scores after adjusting for age, sex, and ICV.</p></sec><sec id="Sec19"><title>Longitudinal volume changes in amygdala subdivisions</title><p id="Par28">The ECT group demonstrated significant Pre-to-Post volume increases in both the BL (Left: &#x003b2;&#x02009;=&#x02009;0.49, <italic>SE</italic>&#x02009;=&#x02009;0.08, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, &#x003bc;&#x02009;=&#x02009;5.9%; Right: &#x003b2;&#x02009;=&#x02009;0.48, <italic>SE</italic>&#x02009;=&#x02009;0.08, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, &#x003bc;&#x02009;=&#x02009;6.2%) and BM (Left: &#x003b2;&#x02009;=&#x02009;0.40, <italic>SE</italic>&#x02009;=&#x02009;0.05, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, &#x003bc;&#x02009;=&#x02009;6.7%; Right: &#x003b2;&#x02009;=&#x02009;0.35, <italic>SE</italic>&#x02009;=&#x02009;0.07, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, &#x003bc;&#x02009;=&#x02009;5.8%) subdivisions, followed by significant Post-to-6MA volume decreases in both the BL (Left: &#x003b2;&#x02009;=&#x02009;&#x02212;0.25, <italic>SE</italic>&#x02009;=&#x02009;.07, <italic>P</italic>&#x02009;=&#x02009;0.003, &#x003bc;&#x02009;=&#x02009;&#x02212;3.0%; Right: &#x003b2;&#x02009;=&#x02009;&#x02212;0.26, <italic>SE</italic>&#x02009;=&#x02009;0.07, <italic>P</italic>&#x02009;=&#x02009;0.001, &#x003bc;&#x02009;=&#x02009;&#x02212;3.4%) and BM (Left: &#x003b2;&#x02009;=&#x02009;&#x02212;0.23, <italic>SE</italic>&#x02009;=&#x02009;0.04, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, &#x003bc;&#x02009;=&#x02009;&#x02212;3.6%; Right: &#x003b2;&#x02009;=&#x02009;&#x02212;0.20, <italic>SE</italic>&#x02009;=&#x02009;0.05, <italic>P</italic>&#x02009;=&#x02009;0.001, &#x003bc;&#x02009;=&#x02009;&#x02212;3.4%) subdivisions (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>, Supplementary Figs.&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>, <xref rid="MOESM1" ref-type="media">3</xref>, Table&#x000a0;<xref rid="MOESM1" ref-type="media">S6</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><title>Longitudinal changes in amygdala subdivision volumes.</title><p><bold>A</bold> Percentage volume changes of the amygdala subdivisions for each group. <bold>B</bold> Heatmaps depicting mean percentage volume changes for the ECT group. ECT electroconvulsive therapy, CBT cognitive behavioral therapy, TMS transcranial magnetic stimulation, BL Basolateral, BM Basomedial. *: <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 Bonferroni corrected.</p></caption><graphic xlink:href="41380_2024_2874_Fig3_HTML" id="d33e1382"/></fig></p><p id="Par29">The left BL, BM, and right BL subdivisions showed significantly larger volumes at 6MA than those at pre-treatment (Left BL: &#x003b2;&#x02009;=&#x02009;0.12, <italic>SE</italic>&#x02009;=&#x02009;0.04, <italic>P</italic>&#x02009;=&#x02009;0.003, &#x003bc;&#x02009;=&#x02009;2.6%; Left BM: &#x003b2;&#x02009;=&#x02009;0.08, <italic>SE</italic>&#x02009;=&#x02009;0.02, <italic>P</italic>&#x02009;=&#x02009;0.002, &#x003bc;&#x02009;=&#x02009;2.8%; Right BL: &#x003b2;&#x02009;=&#x02009;0.09, <italic>SE</italic>&#x02009;=&#x02009;0.02, <italic>P</italic>&#x02009;=&#x02009;0.001, &#x003bc;&#x02009;=&#x02009;2.4%) (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>, Supplementary Figs.&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>, <xref rid="MOESM1" ref-type="media">3</xref>, Table&#x000a0;<xref rid="MOESM1" ref-type="media">S6</xref>). None of the other treatment groups exhibited significant volume changes between any of the timepoints (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>, Supplementary Figs.&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>, <xref rid="MOESM1" ref-type="media">3</xref>, Table&#x000a0;<xref rid="MOESM1" ref-type="media">S6</xref>). Additionally, ECT-specific volume changes persisted even after adjusting for age and baseline anxiety factor scores (Supplementary Figs.&#x000a0;<xref rid="MOESM1" ref-type="media">S4</xref>, <xref rid="MOESM1" ref-type="media">5</xref> and Tables&#x000a0;<xref rid="MOESM1" ref-type="media">S7</xref>, <xref rid="MOESM1" ref-type="media">8</xref>). There was no association between the number of ECT sessions and volume changes (Supplementary Tables&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref> and <xref rid="MOESM1" ref-type="media">S9</xref>). There were no significant differences in volume changes between remitters and non-remitters at Post (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S6</xref>).</p></sec><sec id="Sec20"><title>Association between volume changes in the amygdala subdivisions and anxiety severity</title><p id="Par30">The Pre-to-6MA volume change in the right BM subdivision exhibited a significant partial correlation with changes in the anxiety factor score (&#x003c1;&#x02009;=&#x02009;&#x02212;0.587, 95% CI&#x02009;=&#x02009;[&#x02212;0.817, &#x02212;0.195], <italic>P</italic>&#x02009;=&#x02009;0.010) (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). None of the volume changes showed significant partial correlations with changes in the total HAMD-17 score (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S7</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><title>Association between changes in amygdala volume and anxiety factor score.</title><p><bold>A</bold> (Left) A heatmap depicting the partial correlation coefficients for Pre-to-Post changes. (Right) Scatterplots for Pre-to-Post changes. <bold>B</bold> (Left) A heatmap depicting the correlation coefficients for Pre-to-6MA changes. (Right) Scatterplots for Pre-to-6MA changes. BL Basolateral, BM Basomedial. *: <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 Bonferroni corrected.</p></caption><graphic xlink:href="41380_2024_2874_Fig4_HTML" id="d33e1480"/></fig></p></sec><sec id="Sec21"><title>Association between baseline amygdala volumes and changes in anxiety severity</title><p id="Par31">Baseline right BL subdivision volumes exhibited a significant partial correlation with Pre-to-6MA changes in the anxiety factor score (&#x003c1;&#x02009;=&#x02009;&#x02212;0.603, 95% CI&#x02009;=&#x02009;[&#x02212;0.825, &#x02212;0.219], <italic>P</italic>&#x02009;=&#x02009;0.010) (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). None of the baseline volumes showed significant partial correlations with changes in the total HAMD-17 score (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S7</xref>).<fig id="Fig5"><label>Fig. 5</label><caption><title>Association between baseline amygdala volumes and changes in anxiety factor score.</title><p><bold>A</bold> (Left) A heatmap depicting the partial correlation coefficients for Pre-to-Post changes. (Right) Scatterplots for Pre-to-Post changes. <bold>B</bold> (Left) A heatmap depicting the correlation coefficients for Pre-to-6MA changes. (Right) Scatterplots for Pre-to-6MA changes. BL Basolateral, BM Basomedial. *: <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 Bonferroni corrected.</p></caption><graphic xlink:href="41380_2024_2874_Fig5_HTML" id="d33e1510"/></fig></p></sec></sec><sec id="Sec22" sec-type="discussion"><title>Discussion</title><p id="Par32">This study investigated short- and long-term volume changes in the amygdala subdivisions following ECT and other treatment modalities. Prior to treatment, both the BL and BM subdivisions of the right amygdala were smaller than those in the healthy control group. A post-treatment volume increase was observed only in the ECT group, followed by a subsequent decrease. At the 6-month follow-up, the amygdala subdivision volumes in the ECT group were significantly larger than those at the pre-treatment. Long-term volume changes in the right BM subdivision significantly correlated with improvements in anxiety symptoms. Finally, the baseline right BL subdivision volume indicated a long-term improvement in anxiety symptoms. These findings established a connection between the nuclei of the amygdala, ECT, and the manifestation of anxiety symptoms in depression, advancing our understanding of the therapeutic effects of ECT and the role of the amygdala in depression.</p><p id="Par33">The current study included four different treatment modalities for depression and collected MRI and clinical data at three timepoints. Unlike previous studies, all treatment groups showed similar remission rates post-treatment [<xref ref-type="bibr" rid="CR4">4</xref>]. This may be because the inclusion criteria for the ECT group necessitates treatment-resistant cases, resulting in a significantly more severe population compared to other treatment groups. Except for the medication group, age was also significantly different between ECT and non-ECT groups. Given these inter-group differences, the following discussion interprets the findings while considering these demographic and clinical variations.</p><p id="Par34">In this study, we initially segmented amygdala nuclei using the FreeSurfer module [<xref ref-type="bibr" rid="CR59">59</xref>]. Although this module offers highly reliable estimates for most nuclei, some exhibit relatively low reliability [<xref ref-type="bibr" rid="CR60">60</xref>]. Furthermore, direct comparisons with prior partitioning methods [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>] are not feasible, which poses an interpretability issue. To address this problem, we clustered the nine nuclei from the FreeSurfer output into three subdivisions based on their anatomical plausibility and proximity [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. We quantified the test-retest reliability using two-time-point data from a healthy control group, confirming enhanced reliability through clustering. This methodology, facilitated by collecting multi-time-point data from the healthy control group, significantly enhanced the reproducibility of the study. Additionally, the clustered subdivisions matched well with the cytoarchitectonically defined atlas and typical partitioning methods commonly used in animal research [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR63">63</xref>], thereby improving the interpretability of the results. Notably, this clustering approach permits comparisons across different time points and individuals while accounting for individual variations in subregional positions.</p><p id="Par35">This study, which included 155 patients with depression, is one of the most extensive investigations comparing amygdala volumes in depression. Pre-treatment right amygdala subdivision volumes in patients with depression were smaller than those in healthy controls, which is consistent with the results of a meta-analysis [<xref ref-type="bibr" rid="CR69">69</xref>] and a previous study with a similar sample size&#x000a0;[<xref ref-type="bibr" rid="CR40">40</xref>]. For older cohorts aged 60 and above, there were no significant differences in baseline volume (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S5</xref>) while the effect sizes were larger than those reported in a previous meta-analysis (<italic>d</italic>&#x02009;=&#x02009;0.208) [<xref ref-type="bibr" rid="CR69">69</xref>]. There was no significant correlation between the pre-treatment volume and baseline HAMD-17, and anxiety factor scores. Previous research has suggested that sex differences in amygdala functionality may exist; therefore, the absence of clinical correlates may be attributed to demographic heterogeneity in patients, such as sex [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR71">71</xref>]. Thus, future studies should consider an analytical design that can handle demographic heterogeneity, such as stratifying patients by sex, to reflect individual differences more accurately.</p><p id="Par36">We observed unique treatment-induced volume changes in the amygdala subdivisions specifically associated with ECT, both in the short- and long-term. The transient increase in volume induced by ECT was followed by a decrease during the follow-up period, which is consistent with previous studies [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. Additionally, the effect sizes of the Pre-to-Post volume increases were comparable to those reported in a previous study [<xref ref-type="bibr" rid="CR72">72</xref>]. The TMS group did not show significant volume changes in this study, although a previous study reported a significant increase in amygdala volume after 6 weeks of TMS sessions [<xref ref-type="bibr" rid="CR73">73</xref>]. Therefore, further validation using a larger sample size is warranted. The medication group in this study did not show significant volume changes, whereas antidepressants were found to increase the amygdala volume [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]. The medication group in this study primarily consisted of add-on cases, necessitating caution in interpreting the results due to the potential impact of past antidepressant use on baseline volume. Future studies focusing on treatment-na&#x000ef;ve subjects may offer a more precise assessment of the influence of antidepressants on amygdala volume.</p><p id="Par37">In this study, Pre-to-6MA volume increases in the right BM subdivision were significantly correlated with improvements in anxiety symptoms. The basomedial amygdala may play a distinct role in anxiety, as an animal study reported that the basomedial amygdala, but not the basolateral amygdala mediates the top-down control of anxiety [<xref ref-type="bibr" rid="CR75">75</xref>]. Considering that activation of the basomedial amygdala ameliorates high-anxiety states as indicated in the previous study, an ECT-induced volume increase in basomedial amygdala may facilitate enhanced activation, leading to an improvement in anxiety states. Additionally, human studies have shown that the basolateral and basomedial amygdalae have different connectivity profiles [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR76">76</xref>]. These findings underscore the importance of analyzing the amygdala at the nucleus level.</p><p id="Par38">Furthermore, baseline volume of the right BL subdivision was identified as a potential biomarker for predicting improvements in anxiety symptoms. This finding is consistent with a previous study demonstrating that a larger amygdala volume predicted a greater improvement in overall depressive symptoms [<xref ref-type="bibr" rid="CR25">25</xref>]. When all treatment groups were included, the baseline right BL subdivision volume was not predictive of anxiety improvement (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S9</xref>). Together with the results of the cross-sectional analysis in this study, this indicates that, while the right amygdala subdivisions are significantly smaller in patients with depression compared to healthy controls, a relatively larger volume in the right basolateral amygdala is associated with greater improvements in anxiety following ECT.</p><p id="Par39">There is ongoing debate as to whether ECT-specific volume changes are merely by-products of seizure induction or if they contribute to treatment outcomes [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR78">78</xref>]. One study suggested that ECT-induced volume increases were associated with regional electric field changes but not with antidepressant response, implying that these volume changes might not directly influence clinical outcomes [<xref ref-type="bibr" rid="CR78">78</xref>]. Meanwhile, an animal study demonstrated electroconvulsive seizure-induced glial cell proliferation in the amygdala [<xref ref-type="bibr" rid="CR79">79</xref>], suggesting that neuroplastic changes may contribute to the therapeutic effects of ECT. Although research on the amygdala is limited, studies focusing on the hippocampus have reported a broader range of neuroplastic changes, such as increased neuroplasticity markers and enhanced excitatory synaptic density [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Furthermore, a previous study reported that the increase in hippocampal volume following ECT was not due to edema or angiogenesis [<xref ref-type="bibr" rid="CR17">17</xref>], suggesting that distinct neuroplastic effects of ECT may result in volume increases.</p><p id="Par40">Regarding the association between ECT-specific volume increases and treatment effects, previous research has reported conflicting findings [<xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>]. Our findings add to this discourse by demonstrating that ECT-induced amygdala volume changes were not correlated with overall depressive symptoms (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S7</xref>). However, based on the hypothesis that clinical correlates of volume changes are specific to subregions and symptoms, we demonstrated significant associations between amygdala subdivision volumes and improvements in anxiety. These findings emphasize the importance of examining treatment effects at the subregion and symptom levels. A study focusing on healthy participants found that functional connectivity of the amygdala nuclei could predict subclinical mental health dimensions [<xref ref-type="bibr" rid="CR80">80</xref>]. This finding highlights the importance of exploring the functional connectivity of amygdala subdivisions and their relationship with multiple symptom dimensions in patients with depression, thereby advancing our understanding of the underlying mechanisms of depression.</p><p id="Par41">Interestingly, the TMS group showed significant associations between long-term changes in the left amygdala subdivisions and anxiety improvements, albeit showing insignificant volume changes (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S8</xref>). Furthermore, smaller baseline left BL volumes significantly correlated with long-term anxiety symptom improvements (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S8</xref>). Despite the inconsistent laterality, both the ECT and TMS groups exhibited that larger changes in amygdala subdivision volumes are associated with greater improvements in anxiety. In contrast, when examining the association between baseline amygdala volume and anxiety improvement, these groups showed opposite correlation coefficients; larger baseline right BL volumes correlated with greater anxiety improvement in the ECT group, while smaller baseline left BL volumes correlated with greater anxiety improvement in the TMS group. While the correlation directions differ between treatment modalities, these findings are consistent with previous studies. Doesschate et al. [<xref ref-type="bibr" rid="CR25">25</xref>] reported larger baseline amygdala volumes as predictive of greater improvement in depressive symptoms following ECT, and Furtado et al. [<xref ref-type="bibr" rid="CR81">81</xref>] reported smaller baseline right amygdala volume as predictive of greater improvement in depressive symptoms following TMS. The inconsistency in correlation directions between ECT and TMS may reflect their distinct mechanisms of action and warrants further investigation.</p><p id="Par42">This study has some limitations, including its observational design, which resulted in differences in severity and demographic characteristics between the treatment groups, as well as variations in the ECT treatment protocols. Since the ECT group consisted of treatment-resistant cases, which differed from the populations in the other treatment groups, caution is advised when interpreting the specificity of the volume changes associated with ECT. In addition, the test-retest reliability of the CM subdivision remained low even after clustering. Given that the centromedial amygdala is considered a key region in affective and behavioral processes [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR35">35</xref>], future research should focus on identifying the centromedial amygdala using ultra-high-resolution MRI images or deep learning-based automated segmentation [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR82">82</xref>]. Finally, it is desirable for future studies to validate the current findings using a larger sample size of the ECT group.</p><p id="Par43">In summary, this study discovered ECT-specific amygdala volume changes at the subdivision level over both short- and long-term periods. Additionally, this study identified correlations between right basomedial amygdala volumes and improvements in anxiety symptoms. Furthermore, baseline volumes in the basolateral amygdala significantly correlated with improvements in anxiety. These findings provide insight into the amygdala as a potential biomarker for depression treatment and highlight the importance of examining treatment outcomes at fine-grained levels, considering localized brain regions and specific symptom dimensions.</p></sec><sec id="Sec23" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41380_2024_2874_MOESM1_ESM.docx"><caption><p>supplementary_information</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41380-024-02874-1.</p></sec><ack><title>Acknowledgements</title><p>This study was supported by a Grant-in-Aid for the Strategic International Brain Science Research Promotion Program (Brain/MINDS Beyond) [grant number: JP19dm0307102 to TM] from the Japan Agency for Medical Research and Development (AMED), KAKENHI Grants-in-Aid for Scientific Research C [grant number: 24K10808 to NO] from Japan Society for the Promotion of Science (JSPS), KAKENHI Grants-in-Aid for Scientific Research B [grant number 21H02849 to TM] from JSPS, and KAKENHI Grants-in-Aid for Scientific Research C [grant number 24K10678 to TS] The funders had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.</p><p>We thank the participants and their families, as well as the clinicians and psychologists who contributed to this study. We would also like to thank Halwa Zakia (Department of Psychiatry, Kyoto University, Kyoto, Japan), and Dr. Joanne C Beer (Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, US) for their help at different stages of this research.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Concept and design: Y Ishikawa, NO, YK, TM, and TS. Supervision: NO and TS. Data acquisition: YK, MH, JH, TN, YY, Y Ito, J Miyata, HI, KT, SM, HK, AT, J Matsumoto, FK, K Nakagome, MM, TM, and TS. Data analysis and interpretation: Y Ishikawa, NO, YK, K Nemoto, YF, Y Izumi, TM, and TS. Manuscript preparation: Y Ishikawa and NO with contribution from all authors.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>Data supporting the findings of this study are available from the corresponding author upon request. The data are not publicly available because they contain information that could compromise the privacy of the research participants.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par44">AT is a postdoctoral fellow from Flemish Science Foundation (FWO) (FWO/1283524N).</p></notes><notes id="FPar2"><title>Ethics approval and consent to participate</title><p id="Par45">All methods reported in the current study were performed in accordance with the Ethical Guidelines for Medical and Biological Research Involving Human Subjects. The approval of the current study was obtained from Keio University School of Medicine Ethics Committee [registration number 20190239], Kyoto University Graduate School and Faculty of Medicine Ethics Committee [registration number C0810], National Center of Neurology and Psychiatry Ethics Committee [registration number A2019-098], and Ethics Committee of the Jikei University School of Medicine [registration number 32-160(10241)]. All participants submitted their written informed consent to participate before the recruitment.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">American Psychiatric Publishing. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, District of Columbia: American Psychiatric Publishing; 2013.</mixed-citation></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>John Rush</surname><given-names>A</given-names></name><name><surname>Trivedi</surname><given-names>MH</given-names></name><name><surname>Wisniewski</surname><given-names>SR</given-names></name><name><surname>Nierenberg</surname><given-names>AA</given-names></name><name><surname>Stewart</surname><given-names>JW</given-names></name><etal/></person-group><article-title>Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report</article-title><source>Am J Psychiatry</source><year>2006</year><volume>163</volume><fpage>1905</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1176/ajp.2006.163.11.1905</pub-id><pub-id pub-id-type="pmid">17074942</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">John Rush A, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. Am J Psychiatry. 2006;163:1905&#x02013;17.<pub-id pub-id-type="pmid">17074942</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Ionescu</surname><given-names>DF</given-names></name><name><surname>Rosenbaum</surname><given-names>JF</given-names></name><name><surname>Alpert</surname><given-names>JE</given-names></name></person-group><article-title>Pharmacological approaches to the challenge of treatment-resistant depression</article-title><source>Dialogues Clin Neurosci</source><year>2015</year><volume>17</volume><fpage>111</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.31887/DCNS.2015.17.2/dionescu</pub-id><pub-id pub-id-type="pmid">26246787</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Ionescu DF, Rosenbaum JF, Alpert JE. Pharmacological approaches to the challenge of treatment-resistant depression. Dialogues Clin Neurosci. 2015;17:111&#x02013;26.<pub-id pub-id-type="pmid">26246787</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Husain</surname><given-names>MM</given-names></name><name><surname>Rush</surname><given-names>AJ</given-names></name><name><surname>Fink</surname><given-names>M</given-names></name><name><surname>Knapp</surname><given-names>R</given-names></name><name><surname>Petrides</surname><given-names>G</given-names></name><name><surname>Rummans</surname><given-names>T</given-names></name><etal/></person-group><article-title>Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT)</article-title><source>J Clin Psychiatry</source><year>2004</year><volume>65</volume><fpage>485</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.4088/JCP.v65n0406</pub-id><pub-id pub-id-type="pmid">15119910</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Husain MM, Rush AJ, Fink M, Knapp R, Petrides G, Rummans T, et al. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT). J Clin Psychiatry. 2004;65:485&#x02013;91.<pub-id pub-id-type="pmid">15119910</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Kellner</surname><given-names>CH</given-names></name><name><surname>Husain</surname><given-names>MM</given-names></name><name><surname>Knapp</surname><given-names>RG</given-names></name><name><surname>McCall</surname><given-names>WV</given-names></name><name><surname>Petrides</surname><given-names>G</given-names></name><name><surname>Rudorfer</surname><given-names>MV</given-names></name><etal/></person-group><article-title>Right unilateral ultrabrief pulse ECT in geriatric depression: phase 1 of the PRIDE study</article-title><source>Am J Psychiatry</source><year>2016</year><volume>173</volume><fpage>1101</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.2016.15081101</pub-id><pub-id pub-id-type="pmid">27418379</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Kellner CH, Husain MM, Knapp RG, McCall WV, Petrides G, Rudorfer MV, et al. Right unilateral ultrabrief pulse ECT in geriatric depression: phase 1 of the PRIDE study. Am J Psychiatry. 2016;173:1101&#x02013;9.<pub-id pub-id-type="pmid">27418379</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Berlim</surname><given-names>MT</given-names></name><name><surname>van den Eynde</surname><given-names>F</given-names></name><name><surname>Tovar-Perdomo</surname><given-names>S</given-names></name><name><surname>Daskalakis</surname><given-names>ZJ</given-names></name></person-group><article-title>Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials</article-title><source>Psychol Med</source><year>2014</year><volume>44</volume><fpage>225</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1017/S0033291713000512</pub-id><pub-id pub-id-type="pmid">23507264</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Berlim MT, van den Eynde F, Tovar-Perdomo S, Daskalakis ZJ. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med. 2014;44:225&#x02013;39.<pub-id pub-id-type="pmid">23507264</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Gaynes</surname><given-names>BN</given-names></name><name><surname>Lloyd</surname><given-names>SW</given-names></name><name><surname>Lux</surname><given-names>L</given-names></name><name><surname>Gartlehner</surname><given-names>G</given-names></name><name><surname>Hansen</surname><given-names>RA</given-names></name><name><surname>Brode</surname><given-names>S</given-names></name><etal/></person-group><article-title>Repetitive transcranial magnetic stimulation for treatment-resistant depression</article-title><source>J Clin Psychiatry</source><year>2014</year><volume>75</volume><fpage>477</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.4088/JCP.13r08815</pub-id><pub-id pub-id-type="pmid">24922485</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Gaynes BN, Lloyd SW, Lux L, Gartlehner G, Hansen RA, Brode S, et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression. J Clin Psychiatry. 2014;75:477&#x02013;89.<pub-id pub-id-type="pmid">24922485</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Cuijpers</surname><given-names>P</given-names></name><name><surname>Berking</surname><given-names>M</given-names></name><name><surname>Andersson</surname><given-names>G</given-names></name><name><surname>Quigley</surname><given-names>L</given-names></name><name><surname>Kleiboer</surname><given-names>A</given-names></name><name><surname>Dobson</surname><given-names>KS</given-names></name></person-group><article-title>A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments</article-title><source>Can J Psychiatry</source><year>2013</year><volume>58</volume><fpage>376</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1177/070674371305800702</pub-id><pub-id pub-id-type="pmid">23870719</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Cuijpers P, Berking M, Andersson G, Quigley L, Kleiboer A, Dobson KS. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry. 2013;58:376&#x02013;85.<pub-id pub-id-type="pmid">23870719</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Kar</surname><given-names>SK</given-names></name></person-group><article-title>How electroconvulsive therapy works?: understanding the neurobiological mechanisms</article-title><source>Clin Psychopharmacol Neurosci</source><year>2017</year><volume>15</volume><fpage>210</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.9758/cpn.2017.15.3.210</pub-id><pub-id pub-id-type="pmid">28783929</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Singh A, Kar SK. How electroconvulsive therapy works?: understanding the neurobiological mechanisms. Clin Psychopharmacol Neurosci. 2017;15:210&#x02013;21.<pub-id pub-id-type="pmid">28783929</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Bouckaert</surname><given-names>F</given-names></name><name><surname>Sienaert</surname><given-names>P</given-names></name><name><surname>Obbels</surname><given-names>J</given-names></name><name><surname>Dols</surname><given-names>A</given-names></name><name><surname>Vandenbulcke</surname><given-names>M</given-names></name><name><surname>Stek</surname><given-names>M</given-names></name><etal/></person-group><article-title>ECT: its brain enabling effects: a review of electroconvulsive therapy-induced structural brain plasticity</article-title><source>J ECT</source><year>2014</year><volume>30</volume><fpage>143</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1097/YCT.0000000000000129</pub-id><pub-id pub-id-type="pmid">24810772</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Bouckaert F, Sienaert P, Obbels J, Dols A, Vandenbulcke M, Stek M, et al. ECT: its brain enabling effects: a review of electroconvulsive therapy-induced structural brain plasticity. J ECT. 2014;30:143&#x02013;51.<pub-id pub-id-type="pmid">24810772</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Yrondi</surname><given-names>A</given-names></name><name><surname>Sporer</surname><given-names>M</given-names></name><name><surname>P&#x000e9;ran</surname><given-names>P</given-names></name><name><surname>Schmitt</surname><given-names>L</given-names></name><name><surname>Arbus</surname><given-names>C</given-names></name><name><surname>Sauvaget</surname><given-names>A</given-names></name></person-group><article-title>Electroconvulsive therapy, depression, the immune system and inflammation: a systematic review</article-title><source>Brain Stimul</source><year>2018</year><volume>11</volume><fpage>29</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.brs.2017.10.013</pub-id><pub-id pub-id-type="pmid">29111078</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Yrondi A, Sporer M, P&#x000e9;ran P, Schmitt L, Arbus C, Sauvaget A. Electroconvulsive therapy, depression, the immune system and inflammation: a systematic review. Brain Stimul. 2018;11:29&#x02013;51.<pub-id pub-id-type="pmid">29111078</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Baldinger</surname><given-names>P</given-names></name><name><surname>Lotan</surname><given-names>A</given-names></name><name><surname>Frey</surname><given-names>R</given-names></name><name><surname>Kasper</surname><given-names>S</given-names></name><name><surname>Lerer</surname><given-names>B</given-names></name><name><surname>Lanzenberger</surname><given-names>R</given-names></name></person-group><article-title>Neurotransmitters and electroconvulsive therapy</article-title><source>J ECT</source><year>2014</year><volume>30</volume><fpage>116</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1097/YCT.0000000000000138</pub-id><pub-id pub-id-type="pmid">24820941</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Baldinger P, Lotan A, Frey R, Kasper S, Lerer B, Lanzenberger R. Neurotransmitters and electroconvulsive therapy. J ECT. 2014;30:116&#x02013;21.<pub-id pub-id-type="pmid">24820941</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Gryglewski</surname><given-names>G</given-names></name><name><surname>Lanzenberger</surname><given-names>R</given-names></name><name><surname>Silberbauer</surname><given-names>LR</given-names></name><name><surname>Pacher</surname><given-names>D</given-names></name><name><surname>Kasper</surname><given-names>S</given-names></name><name><surname>Rupprecht</surname><given-names>R</given-names></name><etal/></person-group><article-title>Meta-analysis of brain structural changes after electroconvulsive therapy in depression</article-title><source>Brain Stimul</source><year>2021</year><volume>14</volume><fpage>927</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.brs.2021.05.014</pub-id><pub-id pub-id-type="pmid">34119669</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Gryglewski G, Lanzenberger R, Silberbauer LR, Pacher D, Kasper S, Rupprecht R, et al. Meta-analysis of brain structural changes after electroconvulsive therapy in depression. Brain Stimul. 2021;14:927&#x02013;37.<pub-id pub-id-type="pmid">34119669</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Takamiya</surname><given-names>A</given-names></name><name><surname>Chung</surname><given-names>JK</given-names></name><name><surname>Liang</surname><given-names>K</given-names></name><name><surname>Graff-Guerrero</surname><given-names>A</given-names></name><name><surname>Mimura</surname><given-names>M</given-names></name><name><surname>Kishimoto</surname><given-names>T</given-names></name></person-group><article-title>Effect of electroconvulsive therapy on hippocampal and amygdala volumes: systematic review and meta-analysis</article-title><source>Br J Psychiatry</source><year>2018</year><volume>212</volume><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1192/bjp.2017.11</pub-id><pub-id pub-id-type="pmid">29433612</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Takamiya A, Chung JK, Liang K, Graff-Guerrero A, Mimura M, Kishimoto T. Effect of electroconvulsive therapy on hippocampal and amygdala volumes: systematic review and meta-analysis. Br J Psychiatry. 2018;212:19&#x02013;26.<pub-id pub-id-type="pmid">29433612</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Ousdal</surname><given-names>OT</given-names></name><name><surname>Argyelan</surname><given-names>M</given-names></name><name><surname>Narr</surname><given-names>KL</given-names></name><name><surname>Abbott</surname><given-names>C</given-names></name><name><surname>Wade</surname><given-names>B</given-names></name><name><surname>Vandenbulcke</surname><given-names>M</given-names></name><etal/></person-group><article-title>Brain changes induced by electroconvulsive therapy are broadly distributed</article-title><source>Biol Psychiatry</source><year>2020</year><volume>87</volume><fpage>451</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2019.07.010</pub-id><pub-id pub-id-type="pmid">31561859</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Ousdal OT, Argyelan M, Narr KL, Abbott C, Wade B, Vandenbulcke M, et al. Brain changes induced by electroconvulsive therapy are broadly distributed. Biol Psychiatry. 2020;87:451&#x02013;61.<pub-id pub-id-type="pmid">31561859</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Takamiya</surname><given-names>A</given-names></name><name><surname>Bouckaert</surname><given-names>F</given-names></name><name><surname>Laroy</surname><given-names>M</given-names></name><name><surname>Blommaert</surname><given-names>J</given-names></name><name><surname>Radwan</surname><given-names>A</given-names></name><name><surname>Khatoun</surname><given-names>A</given-names></name><etal/></person-group><article-title>Biophysical mechanisms of electroconvulsive therapy-induced volume expansion in the medial temporal lobe: a longitudinal in vivo human imaging study</article-title><source>Brain Stimul</source><year>2021</year><volume>14</volume><fpage>1038</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.brs.2021.06.011</pub-id><pub-id pub-id-type="pmid">34182182</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Takamiya A, Bouckaert F, Laroy M, Blommaert J, Radwan A, Khatoun A, et al. Biophysical mechanisms of electroconvulsive therapy-induced volume expansion in the medial temporal lobe: a longitudinal in vivo human imaging study. Brain Stimul. 2021;14:1038&#x02013;47.<pub-id pub-id-type="pmid">34182182</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Nuninga</surname><given-names>JO</given-names></name><name><surname>Mandl</surname><given-names>RCW</given-names></name><name><surname>Froeling</surname><given-names>M</given-names></name><name><surname>Siero</surname><given-names>JCW</given-names></name><name><surname>Somers</surname><given-names>M</given-names></name><name><surname>Boks</surname><given-names>MP</given-names></name><etal/></person-group><article-title>Vasogenic edema versus neuroplasticity as neural correlates of hippocampal volume increase following electroconvulsive therapy</article-title><source>Brain Stimul</source><year>2020</year><volume>13</volume><fpage>1080</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.brs.2020.04.017</pub-id><pub-id pub-id-type="pmid">32360430</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Nuninga JO, Mandl RCW, Froeling M, Siero JCW, Somers M, Boks MP, et al. Vasogenic edema versus neuroplasticity as neural correlates of hippocampal volume increase following electroconvulsive therapy. Brain Stimul. 2020;13:1080&#x02013;6.<pub-id pub-id-type="pmid">32360430</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Loef</surname><given-names>D</given-names></name><name><surname>Tendolkar</surname><given-names>I</given-names></name><name><surname>van Eijndhoven</surname><given-names>PFP</given-names></name><name><surname>Hoozemans</surname><given-names>JJM</given-names></name><name><surname>Oudega</surname><given-names>ML</given-names></name><name><surname>Rozemuller</surname><given-names>AJM</given-names></name><etal/></person-group><article-title>Electroconvulsive therapy is associated with increased immunoreactivity of neuroplasticity markers in the hippocampus of depressed patients</article-title><source>Transl Psychiatry</source><year>2023</year><volume>13</volume><fpage>355</fpage><pub-id pub-id-type="doi">10.1038/s41398-023-02658-1</pub-id><pub-id pub-id-type="pmid">37981649</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Loef D, Tendolkar I, van Eijndhoven PFP, Hoozemans JJM, Oudega ML, Rozemuller AJM, et al. Electroconvulsive therapy is associated with increased immunoreactivity of neuroplasticity markers in the hippocampus of depressed patients. Transl Psychiatry. 2023;13:355.<pub-id pub-id-type="pmid">37981649</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>Y</given-names></name><name><surname>Yokoyama</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>T</given-names></name><name><surname>Yagishita</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>KF</given-names></name><name><surname>Takamiya</surname><given-names>A</given-names></name></person-group><article-title>Neurogenesis-independent mechanisms of MRI-detectable hippocampal volume increase following electroconvulsive stimulation</article-title><source>Neuropsychopharmacology</source><year>2024</year><volume>49</volume><fpage>1236</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1038/s41386-023-01791-1</pub-id><pub-id pub-id-type="pmid">38195908</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Abe Y, Yokoyama K, Kato T, Yagishita S, Tanaka KF, Takamiya A. Neurogenesis-independent mechanisms of MRI-detectable hippocampal volume increase following electroconvulsive stimulation. Neuropsychopharmacology. 2024;49:1236&#x02013;45.<pub-id pub-id-type="pmid">38195908</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Dukart</surname><given-names>J</given-names></name><name><surname>Regen</surname><given-names>F</given-names></name><name><surname>Kherif</surname><given-names>F</given-names></name><name><surname>Colla</surname><given-names>M</given-names></name><name><surname>Bajbouj</surname><given-names>M</given-names></name><name><surname>Heuser</surname><given-names>I</given-names></name><etal/></person-group><article-title>Electroconvulsive therapy-induced brain plasticity determines therapeutic outcome in mood disorders</article-title><source>Proc Natl Acad Sci USA</source><year>2014</year><volume>111</volume><fpage>1156</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1073/pnas.1321399111</pub-id><pub-id pub-id-type="pmid">24379394</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Dukart J, Regen F, Kherif F, Colla M, Bajbouj M, Heuser I, et al. Electroconvulsive therapy-induced brain plasticity determines therapeutic outcome in mood disorders. Proc Natl Acad Sci USA. 2014;111:1156&#x02013;61.<pub-id pub-id-type="pmid">24379394</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Jorgensen</surname><given-names>A</given-names></name><name><surname>Magnusson</surname><given-names>P</given-names></name><name><surname>Hanson</surname><given-names>LG</given-names></name><name><surname>Kirkegaard</surname><given-names>T</given-names></name><name><surname>Benveniste</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><etal/></person-group><article-title>Regional brain volumes, diffusivity, and metabolite changes after electroconvulsive therapy for severe depression</article-title><source>Acta Psychiatr Scand</source><year>2016</year><volume>133</volume><fpage>154</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1111/acps.12462</pub-id><pub-id pub-id-type="pmid">26138003</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Jorgensen A, Magnusson P, Hanson LG, Kirkegaard T, Benveniste H, Lee H, et al. Regional brain volumes, diffusivity, and metabolite changes after electroconvulsive therapy for severe depression. Acta Psychiatr Scand. 2016;133:154&#x02013;64.<pub-id pub-id-type="pmid">26138003</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Gbyl</surname><given-names>K</given-names></name><name><surname>Rostrup</surname><given-names>E</given-names></name><name><surname>Raghava</surname><given-names>JM</given-names></name><name><surname>Andersen</surname><given-names>C</given-names></name><name><surname>Rosenberg</surname><given-names>R</given-names></name><name><surname>Larsson</surname><given-names>HBW</given-names></name><etal/></person-group><article-title>Volume of hippocampal subregions and clinical improvement following electroconvulsive therapy in patients with depression</article-title><source>Prog Neuropsychopharmacol Biol Psychiatry</source><year>2021</year><volume>104</volume><fpage>110048</fpage><pub-id pub-id-type="doi">10.1016/j.pnpbp.2020.110048</pub-id><pub-id pub-id-type="pmid">32730916</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Gbyl K, Rostrup E, Raghava JM, Andersen C, Rosenberg R, Larsson HBW, et al. Volume of hippocampal subregions and clinical improvement following electroconvulsive therapy in patients with depression. Prog Neuropsychopharmacol Biol Psychiatry. 2021;104:110048.<pub-id pub-id-type="pmid">32730916</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Brancati</surname><given-names>GE</given-names></name><name><surname>Brekke</surname><given-names>N</given-names></name><name><surname>Bartsch</surname><given-names>H</given-names></name><name><surname>Evjenth S&#x000f8;rhaug</surname><given-names>OJ</given-names></name><name><surname>Ousdal</surname><given-names>OT</given-names></name><name><surname>Hammar</surname><given-names>&#x000c5;</given-names></name><etal/></person-group><article-title>Short and long-term effects of single and multiple sessions of electroconvulsive therapy on brain gray matter volumes</article-title><source>Brain Stimul</source><year>2021</year><volume>14</volume><fpage>1330</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.brs.2021.08.018</pub-id><pub-id pub-id-type="pmid">34464746</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Brancati GE, Brekke N, Bartsch H, Evjenth S&#x000f8;rhaug OJ, Ousdal OT, Hammar &#x000c5;, et al. Short and long-term effects of single and multiple sessions of electroconvulsive therapy on brain gray matter volumes. Brain Stimul. 2021;14:1330&#x02013;9.<pub-id pub-id-type="pmid">34464746</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Sartorius</surname><given-names>A</given-names></name><name><surname>Demirakca</surname><given-names>T</given-names></name><name><surname>B&#x000f6;hringer</surname><given-names>A</given-names></name><name><surname>Clemm von Hohenberg</surname><given-names>C</given-names></name><name><surname>Aksay</surname><given-names>SS</given-names></name><name><surname>Bumb</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Electroconvulsive therapy induced gray matter increase is not necessarily correlated with clinical data in depressed patients</article-title><source>Brain Stimul</source><year>2019</year><volume>12</volume><fpage>335</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.brs.2018.11.017</pub-id><pub-id pub-id-type="pmid">30554869</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Sartorius A, Demirakca T, B&#x000f6;hringer A, Clemm von Hohenberg C, Aksay SS, Bumb JM, et al. Electroconvulsive therapy induced gray matter increase is not necessarily correlated with clinical data in depressed patients. Brain Stimul. 2019;12:335&#x02013;43.<pub-id pub-id-type="pmid">30554869</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Ten Doesschate</surname><given-names>F</given-names></name><name><surname>van Eijndhoven</surname><given-names>P</given-names></name><name><surname>Tendolkar</surname><given-names>I</given-names></name><name><surname>van Wingen</surname><given-names>GA</given-names></name><name><surname>van Waarde</surname><given-names>JA</given-names></name></person-group><article-title>Pre-treatment amygdala volume predicts electroconvulsive therapy response</article-title><source>Front Psychiatry</source><year>2014</year><volume>5</volume><fpage>169</fpage><pub-id pub-id-type="pmid">25505429</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Ten Doesschate F, van Eijndhoven P, Tendolkar I, van Wingen GA, van Waarde JA. Pre-treatment amygdala volume predicts electroconvulsive therapy response. Front Psychiatry. 2014;5:169.<pub-id pub-id-type="pmid">25505429</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Gryglewski</surname><given-names>G</given-names></name><name><surname>Baldinger-Melich</surname><given-names>P</given-names></name><name><surname>Seiger</surname><given-names>R</given-names></name><name><surname>Godbersen</surname><given-names>GM</given-names></name><name><surname>Michenthaler</surname><given-names>P</given-names></name><name><surname>Kl&#x000f6;bl</surname><given-names>M</given-names></name><etal/></person-group><article-title>Structural changes in amygdala nuclei, hippocampal subfields and cortical thickness following electroconvulsive therapy in treatment-resistant depression: longitudinal analysis</article-title><source>Br J Psychiatry</source><year>2019</year><volume>214</volume><fpage>159</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1192/bjp.2018.224</pub-id><pub-id pub-id-type="pmid">30442205</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Gryglewski G, Baldinger-Melich P, Seiger R, Godbersen GM, Michenthaler P, Kl&#x000f6;bl M, et al. Structural changes in amygdala nuclei, hippocampal subfields and cortical thickness following electroconvulsive therapy in treatment-resistant depression: longitudinal analysis. Br J Psychiatry. 2019;214:159&#x02013;67.<pub-id pub-id-type="pmid">30442205</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>M</given-names></name></person-group><article-title>The role of the amygdala in fear and anxiety</article-title><source>Annu Rev Neurosci</source><year>1992</year><volume>15</volume><fpage>353</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1146/annurev.ne.15.030192.002033</pub-id><pub-id pub-id-type="pmid">1575447</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Davis M. The role of the amygdala in fear and anxiety. Annu Rev Neurosci. 1992;15:353&#x02013;75.<pub-id pub-id-type="pmid">1575447</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Juranek</surname><given-names>J</given-names></name><name><surname>Filipek</surname><given-names>PA</given-names></name><name><surname>Berenji</surname><given-names>GR</given-names></name><name><surname>Modahl</surname><given-names>C</given-names></name><name><surname>Osann</surname><given-names>K</given-names></name><name><surname>Spence</surname><given-names>MA</given-names></name></person-group><article-title>Association between amygdala volume and anxiety level: magnetic resonance imaging (MRI) study in autistic children</article-title><source>J Child Neurol</source><year>2006</year><volume>21</volume><fpage>1051</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1177/7010.2006.00237</pub-id><pub-id pub-id-type="pmid">17156697</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Juranek J, Filipek PA, Berenji GR, Modahl C, Osann K, Spence MA. Association between amygdala volume and anxiety level: magnetic resonance imaging (MRI) study in autistic children. J Child Neurol. 2006;21:1051&#x02013;8.<pub-id pub-id-type="pmid">17156697</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>CB</given-names></name><name><surname>Duan</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Supekar</surname><given-names>K</given-names></name><name><surname>Menon</surname><given-names>V</given-names></name></person-group><article-title>Amygdala Subregional structure and intrinsic functional connectivity predicts individual differences in anxiety during early childhood</article-title><source>Biol Psychiatry</source><year>2014</year><volume>75</volume><fpage>892</fpage><lpage>900</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2013.10.006</pub-id><pub-id pub-id-type="pmid">24268662</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Qin S, Young CB, Duan X, Chen T, Supekar K, Menon V. Amygdala Subregional structure and intrinsic functional connectivity predicts individual differences in anxiety during early childhood. Biol Psychiatry. 2014;75:892&#x02013;900.<pub-id pub-id-type="pmid">24268662</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Janak</surname><given-names>PH</given-names></name><name><surname>Tye</surname><given-names>KM</given-names></name></person-group><article-title>From circuits to behaviour in the amygdala</article-title><source>Nature</source><year>2015</year><volume>517</volume><fpage>284</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1038/nature14188</pub-id><pub-id pub-id-type="pmid">25592533</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Janak PH, Tye KM. From circuits to behaviour in the amygdala. Nature. 2015;517:284&#x02013;92.<pub-id pub-id-type="pmid">25592533</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Etkin</surname><given-names>A</given-names></name><name><surname>Prater</surname><given-names>KE</given-names></name><name><surname>Schatzberg</surname><given-names>AF</given-names></name><name><surname>Menon</surname><given-names>V</given-names></name><name><surname>Greicius</surname><given-names>MD</given-names></name></person-group><article-title>Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder</article-title><source>Arch Gen Psychiatry</source><year>2009</year><volume>66</volume><fpage>1361</fpage><pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2009.104</pub-id><pub-id pub-id-type="pmid">19996041</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Etkin A, Prater KE, Schatzberg AF, Menon V, Greicius MD. Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder. Arch Gen Psychiatry. 2009;66:1361.<pub-id pub-id-type="pmid">19996041</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Amunts</surname><given-names>K</given-names></name><name><surname>Kedo</surname><given-names>O</given-names></name><name><surname>Kindler</surname><given-names>M</given-names></name><name><surname>Pieperhoff</surname><given-names>P</given-names></name><name><surname>Mohlberg</surname><given-names>H</given-names></name><name><surname>Shah</surname><given-names>NJ</given-names></name><etal/></person-group><article-title>Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: intersubject variability and probability maps</article-title><source>Anat Embryol</source><year>2005</year><volume>210</volume><fpage>343</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1007/s00429-005-0025-5</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Amunts K, Kedo O, Kindler M, Pieperhoff P, Mohlberg H, Shah NJ, et al. Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: intersubject variability and probability maps. Anat Embryol. 2005;210:343&#x02013;52.</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Phelps</surname><given-names>EA</given-names></name><name><surname>LeDoux</surname><given-names>JE</given-names></name></person-group><article-title>Contributions of the amygdala to emotion processing: from animal models to human behavior</article-title><source>Neuron</source><year>2005</year><volume>48</volume><fpage>175</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2005.09.025</pub-id><pub-id pub-id-type="pmid">16242399</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Phelps EA, LeDoux JE. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron. 2005;48:175&#x02013;87.<pub-id pub-id-type="pmid">16242399</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Tye</surname><given-names>KM</given-names></name><name><surname>Prakash</surname><given-names>R</given-names></name><name><surname>Kim</surname><given-names>S-Y</given-names></name><name><surname>Fenno</surname><given-names>LE</given-names></name><name><surname>Grosenick</surname><given-names>L</given-names></name><name><surname>Zarabi</surname><given-names>H</given-names></name><etal/></person-group><article-title>Amygdala circuitry mediating reversible and bidirectional control of anxiety</article-title><source>Nature</source><year>2011</year><volume>471</volume><fpage>358</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1038/nature09820</pub-id><pub-id pub-id-type="pmid">21389985</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Tye KM, Prakash R, Kim S-Y, Fenno LE, Grosenick L, Zarabi H, et al. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature. 2011;471:358&#x02013;62.<pub-id pub-id-type="pmid">21389985</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Kalin</surname><given-names>NH</given-names></name><name><surname>Shelton</surname><given-names>SE</given-names></name><name><surname>Davidson</surname><given-names>RJ</given-names></name></person-group><article-title>The role of the central nucleus of the amygdala in mediating fear and anxiety in the primate</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>5506</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0292-04.2004</pub-id><pub-id pub-id-type="pmid">15201323</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Kalin NH, Shelton SE, Davidson RJ. The role of the central nucleus of the amygdala in mediating fear and anxiety in the primate. J Neurosci. 2004;24:5506&#x02013;15.<pub-id pub-id-type="pmid">15201323</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Stuber</surname><given-names>GD</given-names></name><name><surname>Sparta</surname><given-names>DR</given-names></name><name><surname>Stamatakis</surname><given-names>AM</given-names></name><name><surname>van Leeuwen</surname><given-names>WA</given-names></name><name><surname>Hardjoprajitno</surname><given-names>JE</given-names></name><name><surname>Cho</surname><given-names>S</given-names></name><etal/></person-group><article-title>Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking</article-title><source>Nature</source><year>2011</year><volume>475</volume><fpage>377</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1038/nature10194</pub-id><pub-id pub-id-type="pmid">21716290</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Stuber GD, Sparta DR, Stamatakis AM, van Leeuwen WA, Hardjoprajitno JE, Cho S, et al. Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking. Nature. 2011;475:377&#x02013;80.<pub-id pub-id-type="pmid">21716290</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Roddy</surname><given-names>D</given-names></name><name><surname>Kelly</surname><given-names>JR</given-names></name><name><surname>Farrell</surname><given-names>C</given-names></name><name><surname>Doolin</surname><given-names>K</given-names></name><name><surname>Roman</surname><given-names>E</given-names></name><name><surname>Nasa</surname><given-names>A</given-names></name><etal/></person-group><article-title>Amygdala substructure volumes in major depressive disorder</article-title><source>Neuroimage Clin</source><year>2021</year><volume>31</volume><fpage>102781</fpage><pub-id pub-id-type="doi">10.1016/j.nicl.2021.102781</pub-id><pub-id pub-id-type="pmid">34384996</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Roddy D, Kelly JR, Farrell C, Doolin K, Roman E, Nasa A, et al. Amygdala substructure volumes in major depressive disorder. Neuroimage Clin. 2021;31:102781.<pub-id pub-id-type="pmid">34384996</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Tesen</surname><given-names>H</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Okamoto</surname><given-names>N</given-names></name><name><surname>Ikenouchi</surname><given-names>A</given-names></name><name><surname>Igata</surname><given-names>R</given-names></name><name><surname>Konishi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Volume of amygdala subregions and clinical manifestations in patients with first-episode, drug-na&#x000ef;ve major depression</article-title><source>Front Hum Neurosci</source><year>2022</year><volume>15</volume><fpage>780884</fpage><pub-id pub-id-type="doi">10.3389/fnhum.2021.780884</pub-id><pub-id pub-id-type="pmid">35046783</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Tesen H, Watanabe K, Okamoto N, Ikenouchi A, Igata R, Konishi Y, et al. Volume of amygdala subregions and clinical manifestations in patients with first-episode, drug-na&#x000ef;ve major depression. Front Hum Neurosci. 2022;15:780884.<pub-id pub-id-type="pmid">35046783</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>SSG</given-names></name><name><surname>Rutland</surname><given-names>JW</given-names></name><name><surname>Verma</surname><given-names>G</given-names></name><name><surname>Feldman</surname><given-names>RE</given-names></name><name><surname>Alper</surname><given-names>J</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><etal/></person-group><article-title>Structural MRI at 7T reveals amygdala nuclei and hippocampal subfield volumetric association with major depressive disorder symptom severity</article-title><source>Sci Rep</source><year>2019</year><volume>9</volume><fpage>10166</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-46687-7</pub-id><pub-id pub-id-type="pmid">31308432</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Brown SSG, Rutland JW, Verma G, Feldman RE, Alper J, Schneider M, et al. Structural MRI at 7T reveals amygdala nuclei and hippocampal subfield volumetric association with major depressive disorder symptom severity. Sci Rep. 2019;9:10166.<pub-id pub-id-type="pmid">31308432</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Han</surname><given-names>K-M</given-names></name><name><surname>Choi</surname><given-names>KW</given-names></name><name><surname>Tae</surname><given-names>W-S</given-names></name><name><surname>Kang</surname><given-names>W</given-names></name><name><surname>Kang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Volumetric alterations in subregions of the amygdala in adults with major depressive disorder</article-title><source>J Affect Disord</source><year>2021</year><volume>295</volume><fpage>108</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2021.08.012</pub-id><pub-id pub-id-type="pmid">34419778</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Kim H, Han K-M, Choi KW, Tae W-S, Kang W, Kang Y, et al. Volumetric alterations in subregions of the amygdala in adults with major depressive disorder. J Affect Disord. 2021;295:108&#x02013;15.<pub-id pub-id-type="pmid">34419778</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Bracht</surname><given-names>T</given-names></name><name><surname>Walther</surname><given-names>S</given-names></name><name><surname>Breit</surname><given-names>S</given-names></name><name><surname>Mertse</surname><given-names>N</given-names></name><name><surname>Federspiel</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>A</given-names></name><etal/></person-group><article-title>Distinct and shared patterns of brain plasticity during electroconvulsive therapy and treatment as usual in depression: an observational multimodal MRI-study</article-title><source>Transl Psychiatry</source><year>2023</year><volume>13</volume><fpage>6</fpage><pub-id pub-id-type="doi">10.1038/s41398-022-02304-2</pub-id><pub-id pub-id-type="pmid">36627288</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Bracht T, Walther S, Breit S, Mertse N, Federspiel A, Meyer A, et al. Distinct and shared patterns of brain plasticity during electroconvulsive therapy and treatment as usual in depression: an observational multimodal MRI-study. Transl Psychiatry. 2023;13:6.<pub-id pub-id-type="pmid">36627288</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>M</given-names></name></person-group><article-title>A rating scale for depression</article-title><source>J Neurol Neurosurg Psychiatry</source><year>1960</year><volume>23</volume><fpage>56</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1136/jnnp.23.1.56</pub-id><pub-id pub-id-type="pmid">14399272</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56&#x02013;62.<pub-id pub-id-type="pmid">14399272</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>AT</given-names></name><name><surname>Steer</surname><given-names>RA</given-names></name></person-group><article-title>Internal consistencies of the original and revised beck depression inventory</article-title><source>J Clin Psychol</source><year>1984</year><volume>40</volume><fpage>1365</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1002/1097-4679(198411)40:6&#x0003c;1365::AID-JCLP2270400615&#x0003e;3.0.CO;2-D</pub-id><pub-id pub-id-type="pmid">6511949</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Beck AT, Steer RA. Internal consistencies of the original and revised beck depression inventory. J Clin Psychol. 1984;40:1365&#x02013;7.<pub-id pub-id-type="pmid">6511949</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Montgomery</surname><given-names>SA</given-names></name><name><surname>&#x000c5;sberg</surname><given-names>M</given-names></name></person-group><article-title>A new depression scale designed to be sensitive to change</article-title><source>Br J Psychiatry</source><year>1979</year><volume>134</volume><fpage>382</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1192/bjp.134.4.382</pub-id><pub-id pub-id-type="pmid">444788</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Montgomery SA, &#x000c5;sberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382&#x02013;9.<pub-id pub-id-type="pmid">444788</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Shafer</surname><given-names>AB</given-names></name></person-group><article-title>Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung</article-title><source>J Clin Psychol</source><year>2006</year><volume>62</volume><fpage>123</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1002/jclp.20213</pub-id><pub-id pub-id-type="pmid">16287149</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Shafer AB. Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung. J Clin Psychol. 2006;62:123&#x02013;46.<pub-id pub-id-type="pmid">16287149</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Fried</surname><given-names>EI</given-names></name><name><surname>Flake</surname><given-names>JK</given-names></name><name><surname>Robinaugh</surname><given-names>DJ</given-names></name></person-group><article-title>Revisiting the theoretical and methodological foundations of depression measurement</article-title><source>Nat Rev Psychol</source><year>2022</year><volume>1</volume><fpage>358</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1038/s44159-022-00050-2</pub-id><pub-id pub-id-type="pmid">38107751</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Fried EI, Flake JK, Robinaugh DJ. Revisiting the theoretical and methodological foundations of depression measurement. Nat Rev Psychol. 2022;1:358&#x02013;68.<pub-id pub-id-type="pmid">38107751</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Drysdale</surname><given-names>AT</given-names></name><name><surname>Grosenick</surname><given-names>L</given-names></name><name><surname>Downar</surname><given-names>J</given-names></name><name><surname>Dunlop</surname><given-names>K</given-names></name><name><surname>Mansouri</surname><given-names>F</given-names></name><name><surname>Meng</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Resting-state connectivity biomarkers define neurophysiological subtypes of depression</article-title><source>Nat Med</source><year>2017</year><volume>23</volume><fpage>28</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1038/nm.4246</pub-id><pub-id pub-id-type="pmid">27918562</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, et al. Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med. 2017;23:28&#x02013;38.<pub-id pub-id-type="pmid">27918562</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Huerta</surname><given-names>PT</given-names></name><name><surname>Volpe</surname><given-names>BT</given-names></name></person-group><article-title>Transcranial magnetic stimulation, synaptic plasticity and network oscillations</article-title><source>J Neuroeng Rehabil</source><year>2009</year><volume>6</volume><fpage>7</fpage><pub-id pub-id-type="doi">10.1186/1743-0003-6-7</pub-id><pub-id pub-id-type="pmid">19254380</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Huerta PT, Volpe BT. Transcranial magnetic stimulation, synaptic plasticity and network oscillations. J Neuroeng Rehabil. 2009;6:7.<pub-id pub-id-type="pmid">19254380</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Ge</surname><given-names>T</given-names></name><name><surname>Leng</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>Z</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><etal/></person-group><article-title>The role of neural plasticity in depression: from hippocampus to prefrontal cortex</article-title><source>Neural Plast</source><year>2017</year><volume>2017</volume><fpage>1</fpage><lpage>11</lpage></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Liu W, Ge T, Leng Y, Pan Z, Fan J, Yang W, et al. The role of neural plasticity in depression: from hippocampus to prefrontal cortex. Neural Plast. 2017;2017:1&#x02013;11.</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Tartt</surname><given-names>AN</given-names></name><name><surname>Mariani</surname><given-names>M</given-names></name><name><surname>Hen</surname><given-names>R</given-names></name><name><surname>Mann</surname><given-names>JJ</given-names></name><name><surname>Boldrini</surname><given-names>M</given-names></name></person-group><article-title>Electroconvulsive therapy&#x02014;a shocking inducer of neuroplasticity?</article-title><source>Mol Psychiatry</source><year>2024</year><volume>29</volume><fpage>35</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1038/s41380-023-02015-0</pub-id><pub-id pub-id-type="pmid">36869226</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Tartt AN, Mariani M, Hen R, Mann JJ, Boldrini M. Electroconvulsive therapy&#x02014;a shocking inducer of neuroplasticity? Mol Psychiatry. 2024;29:35&#x02013;37.<pub-id pub-id-type="pmid">36869226</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Borgers</surname><given-names>T</given-names></name><name><surname>Enneking</surname><given-names>V</given-names></name><name><surname>Klug</surname><given-names>M</given-names></name><name><surname>Garbe</surname><given-names>J</given-names></name><name><surname>Meinert</surname><given-names>H</given-names></name><name><surname>Wulle</surname><given-names>M</given-names></name><etal/></person-group><article-title>Long-term effects of electroconvulsive therapy on brain structure in major depression</article-title><source>Psychol Med</source><year>2024</year><volume>54</volume><fpage>940</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1017/S0033291723002647</pub-id><pub-id pub-id-type="pmid">37681274</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Borgers T, Enneking V, Klug M, Garbe J, Meinert H, Wulle M, et al. Long-term effects of electroconvulsive therapy on brain structure in major depression. Psychol Med. 2024;54:940&#x02013;50.<pub-id pub-id-type="pmid">37681274</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Takamiya</surname><given-names>A</given-names></name><name><surname>Plitman</surname><given-names>E</given-names></name><name><surname>Chung</surname><given-names>JK</given-names></name><name><surname>Chakravarty</surname><given-names>M</given-names></name><name><surname>Graff-Guerrero</surname><given-names>A</given-names></name><name><surname>Mimura</surname><given-names>M</given-names></name><etal/></person-group><article-title>Acute and long-term effects of electroconvulsive therapy on human dentate gyrus</article-title><source>Neuropsychopharmacology</source><year>2019</year><volume>44</volume><fpage>1805</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1038/s41386-019-0312-0</pub-id><pub-id pub-id-type="pmid">30622299</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Takamiya A, Plitman E, Chung JK, Chakravarty M, Graff-Guerrero A, Mimura M, et al. Acute and long-term effects of electroconvulsive therapy on human dentate gyrus. Neuropsychopharmacology. 2019;44:1805&#x02013;11.<pub-id pub-id-type="pmid">30622299</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Kyuragi</surname><given-names>Y</given-names></name><name><surname>Oishi</surname><given-names>N</given-names></name><name><surname>Hatakoshi</surname><given-names>M</given-names></name><name><surname>Hirano</surname><given-names>J</given-names></name><name><surname>Noda</surname><given-names>T</given-names></name><name><surname>Yoshihara</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Segmentation and volume estimation of habenula using deep-learning in patients with depression</article-title><source>Biol Psychiatry Glob Open Sci</source><year>2024</year><volume>4</volume><fpage>100314</fpage><pub-id pub-id-type="doi">10.1016/j.bpsgos.2024.100314</pub-id><pub-id pub-id-type="pmid">38726037</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Kyuragi Y, Oishi N, Hatakoshi M, Hirano J, Noda T, Yoshihara Y, et al. Segmentation and volume estimation of habenula using deep-learning in patients with depression. Biol Psychiatry Glob Open Sci. 2024;4:100314.<pub-id pub-id-type="pmid">38726037</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="other">Jaffe R. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging: a task force report of the American Psychiatric Association, 2nd ed. Am J Psychiatry. 2002;159:331.</mixed-citation></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Tustison</surname><given-names>NJ</given-names></name><name><surname>Avants</surname><given-names>BB</given-names></name><name><surname>Cook</surname><given-names>PA</given-names></name><name><surname>Zheng</surname><given-names>Yuanjie</given-names></name><name><surname>Egan</surname><given-names>A</given-names></name><name><surname>Yushkevich</surname><given-names>PA</given-names></name><etal/></person-group><article-title>N4ITK: improved N3 bias correction</article-title><source>IEEE Trans Med Imaging</source><year>2010</year><volume>29</volume><fpage>1310</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1109/TMI.2010.2046908</pub-id><pub-id pub-id-type="pmid">20378467</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Tustison NJ, Avants BB, Cook PA, Zheng Yuanjie, Egan A, Yushkevich PA, et al. N4ITK: improved N3 bias correction. IEEE Trans Med Imaging. 2010;29:1310&#x02013;20.<pub-id pub-id-type="pmid">20378467</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Reuter</surname><given-names>M</given-names></name><name><surname>Schmansky</surname><given-names>NJ</given-names></name><name><surname>Rosas</surname><given-names>HD</given-names></name><name><surname>Fischl</surname><given-names>B</given-names></name></person-group><article-title>Within-subject template estimation for unbiased longitudinal image analysis</article-title><source>Neuroimage</source><year>2012</year><volume>61</volume><fpage>1402</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.02.084</pub-id><pub-id pub-id-type="pmid">22430496</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Reuter M, Schmansky NJ, Rosas HD, Fischl B. Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage. 2012;61:1402&#x02013;18.<pub-id pub-id-type="pmid">22430496</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Reuter</surname><given-names>M</given-names></name><name><surname>Rosas</surname><given-names>HD</given-names></name><name><surname>Fischl</surname><given-names>B</given-names></name></person-group><article-title>Highly accurate inverse consistent registration: a robust approach</article-title><source>Neuroimage</source><year>2010</year><volume>53</volume><fpage>1181</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.07.020</pub-id><pub-id pub-id-type="pmid">20637289</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Reuter M, Rosas HD, Fischl B. Highly accurate inverse consistent registration: a robust approach. Neuroimage. 2010;53:1181&#x02013;96.<pub-id pub-id-type="pmid">20637289</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Iglesias</surname><given-names>JE</given-names></name><name><surname>Van Leemput</surname><given-names>K</given-names></name><name><surname>Augustinack</surname><given-names>J</given-names></name><name><surname>Insausti</surname><given-names>R</given-names></name><name><surname>Fischl</surname><given-names>B</given-names></name><name><surname>Reuter</surname><given-names>M</given-names></name></person-group><article-title>Bayesian longitudinal segmentation of hippocampal substructures in brain MRI using subject-specific atlases</article-title><source>Neuroimage</source><year>2016</year><volume>141</volume><fpage>542</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2016.07.020</pub-id><pub-id pub-id-type="pmid">27426838</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Iglesias JE, Van Leemput K, Augustinack J, Insausti R, Fischl B, Reuter M. Bayesian longitudinal segmentation of hippocampal substructures in brain MRI using subject-specific atlases. Neuroimage. 2016;141:542&#x02013;55.<pub-id pub-id-type="pmid">27426838</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Saygin</surname><given-names>ZM</given-names></name><name><surname>Kliemann</surname><given-names>D</given-names></name><name><surname>Iglesias</surname><given-names>JE</given-names></name><name><surname>van der Kouwe</surname><given-names>AJW</given-names></name><name><surname>Boyd</surname><given-names>E</given-names></name><name><surname>Reuter</surname><given-names>M</given-names></name><etal/></person-group><article-title>High-resolution magnetic resonance imaging reveals nuclei of the human amygdala: manual segmentation to automatic atlas</article-title><source>Neuroimage</source><year>2017</year><volume>155</volume><fpage>370</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.04.046</pub-id><pub-id pub-id-type="pmid">28479476</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Saygin ZM, Kliemann D, Iglesias JE, van der Kouwe AJW, Boyd E, Reuter M, et al. High-resolution magnetic resonance imaging reveals nuclei of the human amygdala: manual segmentation to automatic atlas. Neuroimage. 2017;155:370&#x02013;82.<pub-id pub-id-type="pmid">28479476</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Quattrini</surname><given-names>G</given-names></name><name><surname>Pievani</surname><given-names>M</given-names></name><name><surname>Jovicich</surname><given-names>J</given-names></name><name><surname>Aiello</surname><given-names>M</given-names></name><name><surname>Bargall&#x000f3;</surname><given-names>N</given-names></name><name><surname>Barkhof</surname><given-names>F</given-names></name><etal/></person-group><article-title>Amygdalar nuclei and hippocampal subfields on MRI: test-retest reliability of automated volumetry across different MRI sites and vendors</article-title><source>Neuroimage</source><year>2020</year><volume>218</volume><fpage>116932</fpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2020.116932</pub-id><pub-id pub-id-type="pmid">32416226</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Quattrini G, Pievani M, Jovicich J, Aiello M, Bargall&#x000f3; N, Barkhof F, et al. Amygdalar nuclei and hippocampal subfields on MRI: test-retest reliability of automated volumetry across different MRI sites and vendors. Neuroimage. 2020;218:116932.<pub-id pub-id-type="pmid">32416226</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Sawada</surname><given-names>M</given-names></name><name><surname>Adolphs</surname><given-names>R</given-names></name><name><surname>Dlouhy</surname><given-names>BJ</given-names></name><name><surname>Jenison</surname><given-names>RL</given-names></name><name><surname>Rhone</surname><given-names>AE</given-names></name><name><surname>Kovach</surname><given-names>CK</given-names></name><etal/></person-group><article-title>Mapping effective connectivity of human amygdala subdivisions with intracranial stimulation</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><fpage>4909</fpage><pub-id pub-id-type="doi">10.1038/s41467-022-32644-y</pub-id><pub-id pub-id-type="pmid">35987994</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Sawada M, Adolphs R, Dlouhy BJ, Jenison RL, Rhone AE, Kovach CK, et al. Mapping effective connectivity of human amygdala subdivisions with intracranial stimulation. Nat Commun. 2022;13:4909.<pub-id pub-id-type="pmid">35987994</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Sylvester</surname><given-names>CM</given-names></name><name><surname>Yu</surname><given-names>Q</given-names></name><name><surname>Srivastava</surname><given-names>AB</given-names></name><name><surname>Marek</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>A</given-names></name><name><surname>Alexopoulos</surname><given-names>D</given-names></name><etal/></person-group><article-title>Individual-specific functional connectivity of the amygdala: A substrate for precision psychiatry</article-title><source>Proc Natl Acad Sci USA</source><year>2020</year><volume>117</volume><fpage>3808</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1073/pnas.1910842117</pub-id><pub-id pub-id-type="pmid">32015137</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Sylvester CM, Yu Q, Srivastava AB, Marek S, Zheng A, Alexopoulos D, et al. Individual-specific functional connectivity of the amygdala: A substrate for precision psychiatry. Proc Natl Acad Sci USA. 2020;117:3808&#x02013;18.<pub-id pub-id-type="pmid">32015137</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>LeDoux</surname><given-names>J</given-names></name></person-group><article-title>The amygdala</article-title><source>Curr Biol</source><year>2007</year><volume>17</volume><fpage>R868</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2007.08.005</pub-id><pub-id pub-id-type="pmid">17956742</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">LeDoux J. The amygdala. Curr Biol. 2007;17:R868&#x02013;74.<pub-id pub-id-type="pmid">17956742</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Morey</surname><given-names>RA</given-names></name><name><surname>Selgrade</surname><given-names>ES</given-names></name><name><surname>Wagner</surname><given-names>HR</given-names></name><name><surname>Huettel</surname><given-names>SA</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>McCarthy</surname><given-names>G</given-names></name></person-group><article-title>Scan&#x02013;rescan reliability of subcortical brain volumes derived from automated segmentation</article-title><source>Hum Brain Mapp</source><year>2010</year><volume>31</volume><fpage>1751</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1002/hbm.20973</pub-id><pub-id pub-id-type="pmid">20162602</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Morey RA, Selgrade ES, Wagner HR, Huettel SA, Wang L, McCarthy G. Scan&#x02013;rescan reliability of subcortical brain volumes derived from automated segmentation. Hum Brain Mapp. 2010;31:1751&#x02013;62.<pub-id pub-id-type="pmid">20162602</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Beer</surname><given-names>JC</given-names></name><name><surname>Tustison</surname><given-names>NJ</given-names></name><name><surname>Cook</surname><given-names>PA</given-names></name><name><surname>Davatzikos</surname><given-names>C</given-names></name><name><surname>Sheline</surname><given-names>YI</given-names></name><name><surname>Shinohara</surname><given-names>RT</given-names></name><etal/></person-group><article-title>Longitudinal ComBat: a method for harmonizing longitudinal multi-scanner imaging data</article-title><source>Neuroimage</source><year>2020</year><volume>220</volume><fpage>117129</fpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2020.117129</pub-id><pub-id pub-id-type="pmid">32640273</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Beer JC, Tustison NJ, Cook PA, Davatzikos C, Sheline YI, Shinohara RT, et al. Longitudinal ComBat: a method for harmonizing longitudinal multi-scanner imaging data. Neuroimage. 2020;220:117129.<pub-id pub-id-type="pmid">32640273</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Fortin</surname><given-names>J-P</given-names></name><name><surname>Parker</surname><given-names>D</given-names></name><name><surname>Tun&#x000e7;</surname><given-names>B</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Elliott</surname><given-names>MA</given-names></name><name><surname>Ruparel</surname><given-names>K</given-names></name><etal/></person-group><article-title>Harmonization of multi-site diffusion tensor imaging data</article-title><source>Neuroimage</source><year>2017</year><volume>161</volume><fpage>149</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.08.047</pub-id><pub-id pub-id-type="pmid">28826946</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Fortin J-P, Parker D, Tun&#x000e7; B, Watanabe T, Elliott MA, Ruparel K, et al. Harmonization of multi-site diffusion tensor imaging data. Neuroimage. 2017;161:149&#x02013;70.<pub-id pub-id-type="pmid">28826946</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Fortin</surname><given-names>J-P</given-names></name><name><surname>Cullen</surname><given-names>N</given-names></name><name><surname>Sheline</surname><given-names>YI</given-names></name><name><surname>Taylor</surname><given-names>WD</given-names></name><name><surname>Aselcioglu</surname><given-names>I</given-names></name><name><surname>Cook</surname><given-names>PA</given-names></name><etal/></person-group><article-title>Harmonization of cortical thickness measurements across scanners and sites</article-title><source>Neuroimage</source><year>2018</year><volume>167</volume><fpage>104</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.11.024</pub-id><pub-id pub-id-type="pmid">29155184</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Fortin J-P, Cullen N, Sheline YI, Taylor WD, Aselcioglu I, Cook PA, et al. Harmonization of cortical thickness measurements across scanners and sites. Neuroimage. 2018;167:104&#x02013;20.<pub-id pub-id-type="pmid">29155184</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Seem&#x000fc;ller</surname><given-names>F</given-names></name><name><surname>Schennach</surname><given-names>R</given-names></name><name><surname>Musil</surname><given-names>R</given-names></name><name><surname>Obermeier</surname><given-names>M</given-names></name><name><surname>Adli</surname><given-names>M</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><etal/></person-group><article-title>A factor analytic comparison of three commonly used depression scales (HAMD, MADRS, BDI) in a large sample of depressed inpatients</article-title><source>BMC Psychiatry</source><year>2023</year><volume>23</volume><fpage>548</fpage><pub-id pub-id-type="doi">10.1186/s12888-023-05038-7</pub-id><pub-id pub-id-type="pmid">37507656</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Seem&#x000fc;ller F, Schennach R, Musil R, Obermeier M, Adli M, Bauer M, et al. A factor analytic comparison of three commonly used depression scales (HAMD, MADRS, BDI) in a large sample of depressed inpatients. BMC Psychiatry. 2023;23:548.<pub-id pub-id-type="pmid">37507656</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>JP</given-names></name><name><surname>Siemer</surname><given-names>M</given-names></name><name><surname>Gotlib</surname><given-names>IH</given-names></name></person-group><article-title>Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies</article-title><source>Mol Psychiatry</source><year>2008</year><volume>13</volume><fpage>993</fpage><lpage>1000</lpage><pub-id pub-id-type="doi">10.1038/mp.2008.57</pub-id><pub-id pub-id-type="pmid">18504424</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Hamilton JP, Siemer M, Gotlib IH. Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Mol Psychiatry. 2008;13:993&#x02013;1000.<pub-id pub-id-type="pmid">18504424</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name><surname>Kogler</surname><given-names>L</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>VI</given-names></name><name><surname>Seidel</surname><given-names>E-M</given-names></name><name><surname>Boubela</surname><given-names>R</given-names></name><name><surname>Kalcher</surname><given-names>K</given-names></name><name><surname>Moser</surname><given-names>E</given-names></name><etal/></person-group><article-title>Sex differences in the functional connectivity of the amygdalae in association with cortisol</article-title><source>Neuroimage</source><year>2016</year><volume>134</volume><fpage>410</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2016.03.064</pub-id><pub-id pub-id-type="pmid">27039701</pub-id>
</element-citation><mixed-citation id="mc-CR70" publication-type="journal">Kogler L, M&#x000fc;ller VI, Seidel E-M, Boubela R, Kalcher K, Moser E, et al. Sex differences in the functional connectivity of the amygdalae in association with cortisol. Neuroimage. 2016;134:410&#x02013;23.<pub-id pub-id-type="pmid">27039701</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>McRae</surname><given-names>K</given-names></name><name><surname>Ochsner</surname><given-names>KN</given-names></name><name><surname>Mauss</surname><given-names>IB</given-names></name><name><surname>Gabrieli</surname><given-names>JJD</given-names></name><name><surname>Gross</surname><given-names>JJ</given-names></name></person-group><article-title>Gender differences in emotion regulation: an fMRI study of cognitive reappraisal</article-title><source>Group Process Intergroup Relat</source><year>2008</year><volume>11</volume><fpage>143</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1177/1368430207088035</pub-id><pub-id pub-id-type="pmid">29743808</pub-id>
</element-citation><mixed-citation id="mc-CR71" publication-type="journal">McRae K, Ochsner KN, Mauss IB, Gabrieli JJD, Gross JJ. Gender differences in emotion regulation: an fMRI study of cognitive reappraisal. Group Process Intergroup Relat. 2008;11:143&#x02013;62.<pub-id pub-id-type="pmid">29743808</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Argyelan</surname><given-names>M</given-names></name><name><surname>Deng</surname><given-names>Z</given-names></name><name><surname>De</surname></name><name><surname>Ousdal</surname><given-names>OT</given-names></name><name><surname>Oltedal</surname><given-names>L</given-names></name><name><surname>Angulo</surname><given-names>B</given-names></name><etal/></person-group><article-title>Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression</article-title><source>Mol Psychiatry</source><year>2024</year><volume>29</volume><fpage>229</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1038/s41380-023-02318-2</pub-id><pub-id pub-id-type="pmid">37985787</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Argyelan M, Deng Z, De, Ousdal OT, Oltedal L, Angulo B, et al. Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression. Mol Psychiatry. 2024;29:229&#x02013;37.<pub-id pub-id-type="pmid">37985787</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Seewoo</surname><given-names>BJ</given-names></name><name><surname>Rodger</surname><given-names>J</given-names></name><name><surname>Demitrack</surname><given-names>MA</given-names></name><name><surname>Heart</surname><given-names>KL</given-names></name><name><surname>Port</surname><given-names>JD</given-names></name><name><surname>Strawn</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Neurostructural differences in adolescents with treatment-resistant depression and treatment effects of transcranial magnetic stimulation</article-title><source>Int J Neuropsychopharmacol</source><year>2022</year><volume>25</volume><fpage>619</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1093/ijnp/pyac007</pub-id><pub-id pub-id-type="pmid">35089358</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Seewoo BJ, Rodger J, Demitrack MA, Heart KL, Port JD, Strawn JR, et al. Neurostructural differences in adolescents with treatment-resistant depression and treatment effects of transcranial magnetic stimulation. Int J Neuropsychopharmacol. 2022;25:619&#x02013;30.<pub-id pub-id-type="pmid">35089358</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Frodl</surname><given-names>T</given-names></name><name><surname>J&#x000e4;ger</surname><given-names>M</given-names></name><name><surname>Smajstrlova</surname><given-names>I</given-names></name><name><surname>Born</surname><given-names>C</given-names></name><name><surname>Bottlender</surname><given-names>R</given-names></name><name><surname>Palladino</surname><given-names>T</given-names></name><etal/></person-group><article-title>Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study</article-title><source>J Psychiatry Neurosci</source><year>2008</year><volume>33</volume><fpage>423</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">18787661</pub-id>
</element-citation><mixed-citation id="mc-CR74" publication-type="journal">Frodl T, J&#x000e4;ger M, Smajstrlova I, Born C, Bottlender R, Palladino T, et al. Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J Psychiatry Neurosci. 2008;33:423&#x02013;30.<pub-id pub-id-type="pmid">18787661</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Adhikari</surname><given-names>A</given-names></name><name><surname>Lerner</surname><given-names>TN</given-names></name><name><surname>Finkelstein</surname><given-names>J</given-names></name><name><surname>Pak</surname><given-names>S</given-names></name><name><surname>Jennings</surname><given-names>JH</given-names></name><name><surname>Davidson</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>Basomedial amygdala mediates top-down control of anxiety and fear</article-title><source>Nature</source><year>2015</year><volume>527</volume><fpage>179</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1038/nature15698</pub-id><pub-id pub-id-type="pmid">26536109</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Adhikari A, Lerner TN, Finkelstein J, Pak S, Jennings JH, Davidson TJ, et al. Basomedial amygdala mediates top-down control of anxiety and fear. Nature. 2015;527:179&#x02013;85.<pub-id pub-id-type="pmid">26536109</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>AK</given-names></name><name><surname>Shehzad</surname><given-names>Z</given-names></name><name><surname>Margulies</surname><given-names>DS</given-names></name><name><surname>Kelly</surname><given-names>AMC</given-names></name><name><surname>Uddin</surname><given-names>LQ</given-names></name><name><surname>Gotimer</surname><given-names>K</given-names></name><etal/></person-group><article-title>Functional connectivity of the human amygdala using resting state fMRI</article-title><source>Neuroimage</source><year>2009</year><volume>45</volume><fpage>614</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2008.11.030</pub-id><pub-id pub-id-type="pmid">19110061</pub-id>
</element-citation><mixed-citation id="mc-CR76" publication-type="journal">Roy AK, Shehzad Z, Margulies DS, Kelly AMC, Uddin LQ, Gotimer K, et al. Functional connectivity of the human amygdala using resting state fMRI. Neuroimage. 2009;45:614&#x02013;26.<pub-id pub-id-type="pmid">19110061</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>Z-D</given-names></name><name><surname>Robins</surname><given-names>PL</given-names></name><name><surname>Regenold</surname><given-names>W</given-names></name><name><surname>Rohde</surname><given-names>P</given-names></name><name><surname>Dannhauer</surname><given-names>M</given-names></name><name><surname>Lisanby</surname><given-names>SH</given-names></name></person-group><article-title>How electroconvulsive therapy works in the treatment of depression: is it the seizure, the electricity, or both?</article-title><source>Neuropsychopharmacology</source><year>2024</year><volume>49</volume><fpage>150</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1038/s41386-023-01677-2</pub-id><pub-id pub-id-type="pmid">37488281</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">Deng Z-D, Robins PL, Regenold W, Rohde P, Dannhauer M, Lisanby SH. How electroconvulsive therapy works in the treatment of depression: is it the seizure, the electricity, or both? Neuropsychopharmacology. 2024;49:150&#x02013;62.<pub-id pub-id-type="pmid">37488281</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name><surname>Argyelan</surname><given-names>M</given-names></name><name><surname>Oltedal</surname><given-names>L</given-names></name><name><surname>Deng</surname><given-names>Z-D</given-names></name><name><surname>Wade</surname><given-names>B</given-names></name><name><surname>Bikson</surname><given-names>M</given-names></name><name><surname>Joanlanne</surname><given-names>A</given-names></name><etal/></person-group><article-title>Electric field causes volumetric changes in the human brain</article-title><source>Elife</source><year>2019</year><volume>8</volume><fpage>e49115</fpage><pub-id pub-id-type="doi">10.7554/eLife.49115</pub-id><pub-id pub-id-type="pmid">31644424</pub-id>
</element-citation><mixed-citation id="mc-CR78" publication-type="journal">Argyelan M, Oltedal L, Deng Z-D, Wade B, Bikson M, Joanlanne A, et al. Electric field causes volumetric changes in the human brain. Elife. 2019;8:e49115.<pub-id pub-id-type="pmid">31644424</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name><surname>Wennstr&#x000f6;m</surname><given-names>M</given-names></name><name><surname>Hellsten</surname><given-names>J</given-names></name><name><surname>Tingstr&#x000f6;m</surname><given-names>A</given-names></name></person-group><article-title>Electroconvulsive seizures induce proliferation of NG2-expressing glial cells in adult rat amygdala</article-title><source>Biol Psychiatry</source><year>2004</year><volume>55</volume><fpage>464</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2003.11.011</pub-id><pub-id pub-id-type="pmid">15023573</pub-id>
</element-citation><mixed-citation id="mc-CR79" publication-type="journal">Wennstr&#x000f6;m M, Hellsten J, Tingstr&#x000f6;m A. Electroconvulsive seizures induce proliferation of NG2-expressing glial cells in adult rat amygdala. Biol Psychiatry. 2004;55:464&#x02013;71.<pub-id pub-id-type="pmid">15023573</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name><surname>Klein-Fl&#x000fc;gge</surname><given-names>MC</given-names></name><name><surname>Jensen</surname><given-names>DEA</given-names></name><name><surname>Takagi</surname><given-names>Y</given-names></name><name><surname>Priestley</surname><given-names>L</given-names></name><name><surname>Verhagen</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Relationship between nuclei-specific amygdala connectivity and mental health dimensions in humans</article-title><source>Nat Hum Behav</source><year>2022</year><volume>6</volume><fpage>1705</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1038/s41562-022-01434-3</pub-id><pub-id pub-id-type="pmid">36138220</pub-id>
</element-citation><mixed-citation id="mc-CR80" publication-type="journal">Klein-Fl&#x000fc;gge MC, Jensen DEA, Takagi Y, Priestley L, Verhagen L, Smith SM, et al. Relationship between nuclei-specific amygdala connectivity and mental health dimensions in humans. Nat Hum Behav. 2022;6:1705&#x02013;22.<pub-id pub-id-type="pmid">36138220</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name><surname>Furtado</surname><given-names>CP</given-names></name><name><surname>Hoy</surname><given-names>KE</given-names></name><name><surname>Maller</surname><given-names>JJ</given-names></name><name><surname>Savage</surname><given-names>G</given-names></name><name><surname>Daskalakis</surname><given-names>ZJ</given-names></name><name><surname>Fitzgerald</surname><given-names>PB</given-names></name></person-group><article-title>An investigation of medial temporal lobe changes and cognition following antidepressant response: a prospective rTMS study</article-title><source>Brain Stimul</source><year>2013</year><volume>6</volume><fpage>346</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.brs.2012.06.006</pub-id><pub-id pub-id-type="pmid">22784443</pub-id>
</element-citation><mixed-citation id="mc-CR81" publication-type="journal">Furtado CP, Hoy KE, Maller JJ, Savage G, Daskalakis ZJ, Fitzgerald PB. An investigation of medial temporal lobe changes and cognition following antidepressant response: a prospective rTMS study. Brain Stimul. 2013;6:346&#x02013;54.<pub-id pub-id-type="pmid">22784443</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name><surname>Greve</surname><given-names>DN</given-names></name><name><surname>Billot</surname><given-names>B</given-names></name><name><surname>Cordero</surname><given-names>D</given-names></name><name><surname>Hoopes</surname><given-names>A</given-names></name><name><surname>Hoffmann</surname><given-names>M</given-names></name><name><surname>Dalca</surname><given-names>AV</given-names></name><etal/></person-group><article-title>A deep learning toolbox for automatic segmentation of subcortical limbic structures from MRI images</article-title><source>Neuroimage</source><year>2021</year><volume>244</volume><fpage>118610</fpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2021.118610</pub-id><pub-id pub-id-type="pmid">34571161</pub-id>
</element-citation><mixed-citation id="mc-CR82" publication-type="journal">Greve DN, Billot B, Cordero D, Hoopes A, Hoffmann M, Dalca AV, et al. A deep learning toolbox for automatic segmentation of subcortical limbic structures from MRI images. Neuroimage. 2021;244:118610.<pub-id pub-id-type="pmid">34571161</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>